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scientific report series published by the
National Institute for Working Life. The
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Preface
An agreement has been signed by the Dutch Expert Committee on Occupational Standards
(DECOS) of the Dutch Health Council and the Swedish Criteria Group for Occupational
Standards (SCG) of the Swedish National Institute for Working Life. The purpose of the
agreement is to write joint scientific criteria documents for occupational exposure limits.
The numerical limits will be developed separately by The Netherlands and Sweden
according to their different national policies.
The evaluation of health effects of Butyl acetates is a product of this agreement. The
draft document was written by H Stouten and W Bogaerts, from the Department of
Occupational Toxicology of the TNO, Nutrition and Food Research Institute, Zeist, the
Netherlands. The document has been reviewed by the Dutch Expert Committee as well as
by the Swedish Criteria Group.
Gerard Mulder Johan Högberg
Chairman Chairman
DECOS SCG
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11. Introduction
As starting point in searching literature on the health effects of exposure to butyl
acetates a number of review articles were used (25, 86, 87, 108, 110, 119). In
addition, literature was retrieved from the on-line data bases CA SEARCH,
MEDLINE and TOXLINE starting from respectively 1967, 1966, and 1965. The
final search has been carried out in January 1997, and included Chem Abs 1997
vol 126/5 (970128/ED), Medline 970128/UP, and Toxline 970128/ED. An
additional literature search in Medline (January 1995-November 2000) and
Toxline (January 1995-September 2000) were performed and where relevant,
these additional data are incorporated in the text. Scientific publications between
1997 and 2000 were no reason for adjustment of the conclusions.
2. Identity, properties, and monitoring
2.1 Identity
2.1.1 Structures
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22.1.2 Chemical identity (106, 119)
n-butyl acetate:
synonyms butyl acetate, butyl ethanoate, acetic acid, butyl ester
CAS registry no 123-86-4
EINECS no 204-658-1
EEC no 607-025-00-1
EEC labelling R: 10
S: (2)
EEC classification R 10
RTECS no AF7350000
isobutyl acetate:
synonyms acetic acid isobutyl ester, 2-methyl-1-propyl acetate,
b-methyl propyl ethanoate
CAS registry no 110-19-0
EINECS no 203-745-1
EEC no 607-026-00-7
EEC labelling R: 11
S: (2-)16-23-29-33
EEC classification F; R 11
RTECS no AI4025000
sec-butyl acetate:
synonyms acetic acid sec-butyl ester, acetic acid 1-methylpropyl
ester, 2-butanol acetate
CAS registry no 105-46-4
EINECS no 203-300-1
EEC no 607-026-00-7
EEC labelling R: 11
S: (2-)16-23-29-33
EEC classification F; R 11
RTECS no AF7380000
tert-butyl acetate:
synonyms acetic acid tert-butyl ester, acetic acid 1,1-dimethyl ethyl
ester
CAS registry no 540-88-5
EINECS no 208-760-7
EEC no 607-026-00-7
EEC labelling R: 11
S: (2-)16-23-29-33
EEC classification F; R 11
RTECS no AF7400000
32.2 Physical and chemical properties (83, 106, 119)
general:
isomers n-butyl acetate, isobutyl acetate, sec-butyl acetate,
tert-butyl acetate
molecular formula C6H12O2
molecular weight 116.16 g/mol
conversion factorsa 1 ppm = 4.83 mg/m3
(20°C, 101.3 kPa) 1 mg/m3 = 0.207 ppm
                                                 
a These conversion factors are used in this document. However, in some cases they might deviate,
since other figures were presented in the publications discussed.
The butyl acetates are colourless, flammable liquids with a fruity odour. Odour
threshold values of 0.031 (determined according to NVN 2820) (70), 0.92 (40),
and 1.88 mg/m3 (8) (0.006, 0.19 and 0.39 ppm, resp.) have been reported. Their
vapours can form explosive mixtures with air. In water or under influence of light,
the acetates slowly decompose into acetic acid and their respective alcohols. They
violently react with oxidising agents. sec-Butyl acetate vapour is heavier than air,
travels along surfaces, and can be ignited from distance.
n-butyl acetate:
boiling point (101.3 kPa) 127 °C
melting point (101.3 kPa) -77 °C
specific gravity (20ºC/4ºC) 0.9
vapour pressure (20ºC) 1.07 kPa
vapour density (air=1) 4.0
relative density of saturated 1.03
vapour/air mixture (air=1; 20ºC)
flash point closed cup: 24 °C; open cup: 37 °C
explosive limits, vol% in air 1.2-7.5
solubility in water (20ºC) 7 g/L
solubility in organic solvents miscible with alcohols, ether, ketones,
esters, most hydrocarbons and other organic
solvents
odour threshold 10 ppm
partition coefficient log Kow 1.82
isobutyl acetate:
boiling point (101.3 kPa) 117 °C
melting point (101.3 kPa) -99 °C
specific gravity (20ºC/4ºC) 0.9
vapour pressure (20ºC) 2.0 kPa
vapour density (air=1) 4.0
4relative density of saturated 1.05
vapour/air mixture (air=1; 20ºC)
flash point closed cup: 17 °C; open cup: 35 °C
explosive limits, vol% in air 2.4-10.5
solubility in water (20ºC) 7 g/L
solubility in organic solvents freely soluble in alcohol, acetone, ether
partition coefficient log Kow 1.60
sec-butyl acetate (exists in D- and L isomeric forms):
boiling point (101.3 kPa) D-form: 112 °C; L-form: 116-117 °C;
DL-racemic: 112.2 °C
melting point (101.3 kPa) -74 °C
specific gravity (20ºC/4ºC) 0.9
vapour pressure (20ºC): 2.5 kPa
vapour density (air=1) 4.0
relative density of saturated 1.1
vapour/air mixture (air=1; 20ºC)
flash point closed cup: 17 °C; open cup: 31 °C
explosive limits, vol% in air 1.7-9.8
solubility in water (20ºC) 30 g/L
solubility in organic solvents soluble in alcohol, ether, acetone
tert-butyl acetate
boiling point (101.3 kPa) 97-98 °C
melting point (101.3 kPa) no data available
specific gravity (20°C/4°C) 0.9
vapour pressure no data available
vapour density no data available
flash point closed cup: 17-22 °C
solubility in water practically insoluble
solubility in organic solvents soluble in ethanol, ether
partition coefficient log Kow 1.38
2.3 EU Classification and labelling (11)
According to the 25th Amendment of Annex 1 of Directive 67/548/EEC, n-butyl
acetate is classified as “flammable”, “repeated exposure may cause skin dryness
or cracking”, and “vapours may cause drowsiness and dizziness”, and is labelled
as follows:
Symbols -
Risk phrases R10: flammable
R66: repeated exposure may cause skin dryness or
cracking
R67: vapours may cause drowsiness and dizziness
Safety phrases S25: avoid contact with eyes
5Iso-, sec- and tert-butyl acetate are classified as “highly flammable” and “repeated
exposure may cause skin dryness or cracking”, and are labelled as follows:
Symbols F: highly flammable
Risk phrases R11: highly flammable
R66: repeated exposure may cause skin dryness or
cracking
Safety phrases S16: keep away from source of ignition - No
smoking
S23: do not breathe gas/fumes/vapours/spray
(appropriate wording to be specified by the
manufacturer)
S25: avoid contact with eyes
S29: do not empty into drains
S33: take precautionary measures against static
 discharges
2.4 Validated analytical methods
2.4.1 Environmental monitoring
NIOSH methods are available for measuring the respective butyl acetates (46).
Ten litre of air is sampled on a solid sorbent tube (coconut shell charcoal) and
desorbed with carbon disulphide. Aliquots are analysed by gas chromatography
equipped with a FID. For 10 L air samples, the method is applicable at con-
centration ranges of 352-1,475 mg/m3, 306-1,280 mg/m3, 478-2,005 mg/m3, and
424-1,780 mg/m3 for n-butyl acetate, isobutyl acetate, sec-butyl acetate, and tert-
butyl acetate, respectively.
The use of diffusive samples in monitoring butyl acetate vapours in indoor/
workplace air has been reported (33, 51, 68, 96).
Butyl acetates can be determined by infrared and UV spectroscopy, gas
chromatography, gas chromatography/mass spectrometry, and headspace gas
chromatography (110, 115).
Finally, concentrations of organic solvents including acetic acids, such as n-
butyl acetate were quantitatively and quasi-continuously analysed in the waste air
of a pharmaceutical production facility by means of infrared spectrometry (44).
2.4.2 Biological monitoring
Several chromatographic methods to determine butyl acetate(s) and butyl
alcohol(s), to which the acetate is rapidly hydrolysed in the blood, have been
published including one proposed by USEPA (49, 105, 107, 112).
No validated methods for biological monitoring of workers exposed to butyl
acetate were found.
63. Sources
3.1 Natural occurrence
The n-butyl, isobutyl, and tert-butyl acetates occur naturally among other esters in
bananas and related fruits (25). n-Butyl acetate is also formed during fermentation
in yeast. It has also been found in a wide variety of food products: milk, cheese,
beer, rum, brandy, wine, whisky, cocoa, black tea, coffee, roasted nuts, vinegar
and honey (74). Isobutyl acetate occurs in natural products such as raspberries,
pears, pineapples and natural cocoa aroma (86), black currants, guava, grapes,
melons, peaches, strawberries, tomatoes, soy beans, plums, passion fruit, star fruit
and dill herb (74).
3.2 Man-made sources
3.2.1 Production
All four isomers of butyl acetate are produced by a nucleophilic addition reaction
during slow distillation of acetic acid and the corresponding butyl alcohol in the
presence of sulphuric acid as a catalyst (119).
Isobutyl acetate is also prepared from methyl isobutyl ketone, the sec-butyl
acetate from sec-butyl alcohol and acetic acid anhydride. The synthesis of the D-
and L-forms has been reported (119).
tert-Butyl acetate is only slowly and incompletely formed from its alcohol and
acetic acid; it is mainly produced from acetic acid and isobutylene (119).
Technical grades of butyl acetates contain butyl alcohol as an impurity; small
amounts of water may also be present (108). Commercial grades that are currently
used are more defined and purified than those used in the early 1930s, when
studies on toxicity of these esters began (119).
In cosmetic grade butyl acetate, lesser amounts of n-butyl alcohol, isobutyl
alcohol and traces of n-propyl acetate and isobutyl acetate are present (110).
3.2.2 Uses
Butyl acetates, especially n-butyl acetate and isobutyl acetate, are used as a
solvent in many trades. The Dutch paint industry was reported to have used 1,750
tons of n-butyl acetate and 1,275 tonnes of isobutyl acetate in 1979 (43).
n-butyl acetate is a good solvent for nitrocellulose. It is mainly used as a solvent
and a thinner in the production of nitrocellulose lacquers in the protective coatings
industry. It is also used in the manufacturing of high-polish lacquers and var-
nishes, in a protective low viscosity vehicle coating used in the motor industry and
in liquid floor wax (119). n-Butyl acetate is further used in:
• the cosmetics industry as a solvent in nail polish, base coats, nail polish
removers and other preparations for manicuring (110);
• the food industry as a component in synthetic flavours, as a component used in
articles used for food packaging, and also as a dilutent for dyes in inks for
marking vegetables and fruits (119);
7• the production of artificial leather, shoe and leather glues, photographic films,
plastics, and safety glass (119);
• the pharmaceutical industry as an extractant (119).
Both n-butyl and isobutyl acetate are used in perfumery. Isobutyl acetate is a
component of hydraulic fluids and is used as a solvent in manufacturing lacquers
and paint removers. sec-Butyl acetate serves also as a solvent for nitrocellulose,
nail enamel, and in the production of paper coatings.
tert-Butyl acetate is used as a solvent for lacquers and also as an antiknock
additive in motor fuels (119).
4. Exposure
4.1 General population
4.1.1 Ambient air
In the Netherlands, industrial emissions of butyl acetate into air amounted to
approximately 1,170 and 1,280 tonnes in 1990 and 1988, respectively.
Corresponding figures of isobutyl acetate were 4.2 and 5.6 tonnes (20).
In a German field study, in selected representative households, low levels of n-
butyl acetate were found (n.d.-23 µg/m3). In winter, the total concentration of
volatile organic compounds was 2-3 times higher than during summer (100).
In a Swiss study of new and recently renovated buildings, a concentration of
549 µg/m3 was measured. Butyl acetate was found to be offgassed from a sealing
wax on a cork floor (94).
Concentrations of 0.1 and 4.8 µg/m3 emanating from US industrial and
chemical waste disposal sites have been reported (90).
4.1.2 Water
In the Netherlands, industrial emissions of butyl acetate into surface water were
0.5 and 2.9 tonnes in 1990 and 1988, respectively (20). No other data on the
presence of the butyl acetate isomers in water were found.
4.1.3 Food
n-Butyl acetate was found in apples at a concentration of up to 29.5 mg/kg, and in
grapes, mangoes, melons, and strawberries at an amount of up to 0.1 mg/kg. In
vinegar, concentrations were up to 166 mg/kg. As to drinks, n-butyl acetate was
found in apple juice at levels of up to 2.2 mg/kg, in cider up to 1.3 mg/kg, in beer
up to 0.2 mg/kg, and in weinbrand up to 0.4 mg/kg (74).
sec-Butyl acetate was found in vinegar at concentrations of 43-67 mg/kg (74).
4.2 Working population
A summary of air levels in workplaces is presented in Table 1.
8The occurrence of n-butyl acetate particulates in paint spray aerosols has been
investigated in six US commercial furniture facilities where sealers and lacquers
containing 13-42% (w/w) n-butyl acetate were used. Theoretically, n-butyl acetate
in paint particles will vaporise very quickly (e.g., 0.5-1 s for a 20 micron particle).
In practice, breathing zone eight-hour time-weighted average measurements (24
data sets) showed a mean total (i.e. vapour plus particles) exposure level of 19
mg/m3 (range: 5.2-48.3 mg/m3) of which the particle exposure (mean: 3.8 mg/m3;
range: n.d.-11.0 mg/m3) contributed about 20% (117).
Table 1. Occupational air levels (personal air sampling).
work isomer mean concentration
in mg/m3 (ppm)
concentration
range in mg/m3
ref.
paint industry n-butyl acetate - 13, 17a 92
paint industry n-butyl acetate 9.7 (2.0) 0-200 114
paint industry n-butyl acetate 9 (1.9)b 1-1680 73
paint industry n-butyl acetate
isobutyl acetate
up to 330
up to 110
18
glue manufacture n-butyl acetate up to 17 113
painter’s workplace isobutyl acetate - 4-58 43
lacquering furniture n-butyl acetate
isobutyl acetate
- 0.3-120
0.2-486
43
lacquering brushes
(dipping)
n-butyl acetate - 4-50 43
indoor painting
(brushing, rolling)
butyl acetate - 2-6 99
indoor painting
(rolling water-based paint)
butyl acetate 0.006 (0.001) up to 0.030 85
spray painting butyl acetate - 54, 65c 99
spray painting butyl acetate - 22.3-76.5 111
spray painting butyl acetate 33 (6.8) up to 629 71
spray painting butyl acetate 9 (1.9) - 7
spray painting n-butyl acetate 19 (3.9) 5.2-48.3 117
spray painting n-butyl acetate
isobutyl acetate
-
-
16.5-180
37.6-134.0
39
spray painting butyl acetate 11.7 (2.4) 2-23 118
fingernail sculptors butyl acetate 1.9±2.4 (0.4±0.5) < 0.5-11.2 57
screen printers:
- printing press
- automatic dryer conveyor
  belt
- manual drying
- paint mixing
- screen wash
butyl acetate
55.9±3.9 (11.6±0.8)
12.1±6.3 (2.5±1.3)
21.9±7.3 (4.5±1.5)
16.5±5.3 (3.4±1.1)
413±82.6 (85±17)
-
-
-
-
-
97
an-Butyl acetate was found in two out of 22 air samples.
bMedian concentration.
cData from two subjects.
95. Kinetics
5.1 Absorption
The most common routes of entry into the body are via the lungs and through the
skin. Although no quantitative data on the absorption of the butyl acetate isomers
into the body were found, it can be expected that the butyl acetate isomers would
readily be absorbed by the respiratory tract, the skin, and the gastro-intestinal
tract.
5.2 Distribution
Human blood/air and rat blood/air partition coefficients for n-butyl acetate were
experimentally determined to be 677 and 1,160, respectively; those for isobutyl
acetate were found to be 578 and 880, respectively (64). Some rat tissue/blood
partition coefficients for these acetates are presented in Table 2.
When a single dose of 14C-labelled n-butyl acetate (in 0.9% NaCl), ≈30 mg/kg
bw (16-18 µCi/animal), was injected iv in the tail vein of male Sprague-Dawley
rats (n=32), n-butyl acetate was very rapidly eliminated from the blood (t1/2 0.4
min). [14C]-n-Butyl acetate was detected in brain tissues only within the first 2.5
minutes following dosing, reaching a maximum concentration of 3.8 µg
equivalents/g tissue after approximately two minutes. Of the metabolites, maxi-
mum [14C]-n-butanol levels of 52 and 79 µg equivalents/g tissue were found in
whole blood and brain, respectively, approximately 2.5 minutes postdosing. The
metabolite was rapidly eliminated from both blood and brain (t1/2 ≈1 min) and
twenty minutes after postdosing concentrations were below detection limit.
Concerning other metabolites, n-butyric acid (max. 5.7 µg equivalents/g whole
blood at t=7.4 min, followed by a slow decrease) and polar metabolites (i.e. citric
acid cycle intermediates, glucuronide and sulphate conjugates: max. 12.2 µg
equivalents/g tissue at t=4.2 min) were detected in the whole blood as well, but
hardly in the brain (38).
Nembutal-anaesthetised rats were exposed for one hour to 33,880 mg/m3 of n-
butyl acetate via a tracheal cannula. Within one minute, a nearly constant blood
level of 140 µmol/L (16.3 mg/L) was reached. Within one minute after ending
exposure, n-butyl acetate had been disappeared. Blood levels of n-butanol
increased within 40 minutes to 480 µmol/L (35.6 mg/L). After ending exposure,
n-butanol was eliminated from the blood with a half-life of 5 min (47).
Table 2. Some rat tissue/blood partition coefficients for n-butyl and isobutyl
acetatea (64).
isomer liver kidney brain muscle fat
n-butyl acetate 3.14 2.72 1.85 1.76 17
isobutyl acetate 5.06 4.08 2.65 2.12 21.3
acalculated as (tissue/air)/(blood/air)
10
In a similar experiment, groups of five rats were exposed for five hours to a
n-butyl acetate concentration of 4,840 mg/m3. n-Butyl acetate and n-butanol
concentrations in blood were measured during the first hour at ten-minute
intervals and the next four hours at fifteen-minute intervals. After a steady
increase followed by a slight decrease, the concentration of n-butyl acetate
reached a nearly constant level of 24.6±3.8 µmol/L (2.9±0.4 mg/L) at about one
hour. The concentration of n-butanol followed roughly a similar pattern reaching a
nearly constant level of 52.4±10.3 µmol/L (3.9±0.8 mg/L). When given a single ip
injection of 790 mg/kg bw ethanol after 30 minutes of exposure, the amount of
n-butanol in the blood was doubled. Mean n-butyl acetate levels were slightly
lower (53). Similar experiments were performed in rats with tert-butyl acetate.
Inhalation of 22,264 mg/m3 for two hours resulted in continuously increasing
blood levels to approximately 400 µmol/L (46.5 mg/L). After ending exposure,
tert-butyl acetate was eliminated in two phases with half-lives of 5 and 70 min.
Blood levels of tert-butanol (the metabolite) increased continuously throughout
the experimental period of 300 min (47). When rats inhaled about 2,100 mg/m3,
blood levels of both tert-butyl acetate and tert-butanol steadily increased during
the five-hour experimental period. Tert-butyl acetate levels exceeded those of tert-
butanol. At t=4 h these levels became approximately equal; tert-butyl acetate
levels now reached a plateau value of about 285 µmol/L (33.1 mg/L), while tert-
butanol continued to increase to approximately 340 µmol/L (25.2 mg/L) at the end
of the experiment. During exposure to 4,356 mg/m3 for 4.25 hours, peak concen-
trations of approximately 450 and 550 µmol/L (52.3 and 40.8 mg/L, resp.) were
measured for tert-butyl acetate and tert-butanol, respectively. Thereafter, tert-butyl
acetate levels rapidly declined to approximately 250 µmol/L (29.0 mg/L) within
fifteen minutes (the end of the experiment), while the tert-butanol level remained
constant (53).
5.3 Biotransformation
Butyl acetates may be readily hydrolysed to acetic acid and their respective
alcohols in blood, the liver, the small intestine, and in the respiratory tract, as was
shown in a number of in vitro experiments using homogenates from liver, small
intestine mucosa, and ethmoturbinates (30, 72). In an in vivo experiment, in which
male rats were iv injected with a single dose of 14C-labelled n-butyl acetate of
approximately 30 mg/kg bw, hydrolysis in blood and brain was reported to be
almost complete within three minutes (38). In vitro, when added to blood samples
from human men volunteers or female rats, hydrolysis half-lives of n-butyl acetate
were 4 and 12 min, while those of tert-butyl acetate were 300 and 270 min (47).
The acetic acid is oxidised via the citric acid cycle to carbon dioxide and water.
Isobutanol and n-butanol are rapidly metabolised by alcohol dehydrogenase and
aldehyde dehydrogenase to the corresponding acids that are oxidised further to
carbon dioxide. Small amounts of isobutanol may be excreted unchanged or
conjugated as a glucuronide (116).
11
sec-Butanol is also metabolised by alcohol dehydrogenase and the metabolite
methyl ethyl ketone is excreted in the breath or urine, or is further metabolised
(116).
tert-Butanol, however, is a poor substrate for alcohol dehydrogenase and is only
slowly metabolised in mammals. It is eliminated in urine as a glucuronide
conjugate and as acetone, and via the breath as acetone and carbon dioxide (116).
When alcohol dehydrogenase is involved, metabolism may be inhibited or
retarded by ethanol. When 790 mg ethanol per kg bw was given by ip injection
30 minutes after the start of n-butyl acetate inhalation, the n-butanol concentration
doubled. This increase is explained by substrate competition between both
alcohols and the alcohol dehydrogenase with ethanol in excess (53).
In vitro experiments have demonstrated that oxidative, cytochrome P450-
mediated mechanisms may play a role in the cleavage of acetate esters.
Using microsomes isolated from phenobarbital-induced rat livers, butyl acetate
(10% concentration, higher concentrations disrupt the microsomal suspension),
bound to cytochrome P450 (type I), stimulated CO-inhibitable NADPH oxidation
in a way typical for cytochrome P450 substrates. It did not alter cytochrome P450,
cytochrome b5, and NADPH-cytochrome c reductase levels (63).
For the oxidation of n-butyl acetate by cytochrome P450 2E1, the major
ethanol-inducible isoform purified from rabbit liver, a KM of 1.5 mM and a Vmax of
0.15 nmol aldehyde formed/min/nmol P450 were determined (91).
Using a reconstituted system containing cytochrome P450 2B4, the major
phenobarbital-inducible isoform purified from rabbit liver, sec-butyl acetate was
demonstrated to undergo hydroxylation to an unstable hemiketal (2-hydroxy-2-
acetoxybutane) followed by a nonhydrolytic cleavage to 2-butanone (methyl ethyl
ketone) (91).
5.4 Elimination
n-Butyl acetate is probably excreted partly unchanged via exhaled air and urine,
and partly after transformation in the body. At an inhalatory concentration of
200 mg/m3, 50% of the n-butyl acetate inhaled was reported to be excreted in
exhaled air (9).
With respect to the other isomers, excretion data are available only for the butyl
alcohol isomers.
5.5 Possibilities for biological monitoring
No studies on the relation between inhaled concentrations of butyl acetate and the
excretion of parent compound or metabolites were found. From a communication
in which it was reported that 50% of the amount inhaled was excreted in exhaled
air (see Section 5.4), it may be concluded that measurements of butyl acetate in
exhaled air may offer a method for biological monitoring.
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5.6 Summary and evaluation
No quantitative data on the absorption of butyl acetate isomers are available.
Following a single iv injection of approximately 30 mg/kg bw n-butyl acetate to
rats, n-butyl acetate was rapidly eliminated from the blood (t1/2 0.4 min) and the
brain (only detectable within the first 2.5 min). Concentrations of n-butanol (its
metabolite) in blood and brain reached a maximum after approximately 2.5
minutes and were below detection limits after twenty minutes (t1/2 approx. 1 min).
When rats were exposed to n-butyl acetate via a tracheal cannula to approx.
34,000 mg/m3 (7,000 ppm) for one hour or to approx. 4,800 mg/m3 (1,000 ppm)
for five hours, nearly constant blood levels of n-butyl acetate and n-butanol were
rapidly reached. After ending the one-hour exposure, n-butyl acetate disappeared
from the blood within 1 minute, while n-butanol was eliminated with a half-life of
5 min. Similar experiments in rats with tert-butyl acetate showed continuously
increasing blood levels of both parent compound and metabolite (tert-butanol).
After ending exposure, tert-butyl acetate was eliminated in two phases (half-life:
5 and 70 min), while tert-butanol levels continued to increase or remained
constant depending on exposure conditions.
Biotransformation involves hydrolytic splitting of the ester in acetic acid and
the respective alcohols. For n-butyl acetate this process occurs rapidly in vivo in
rats and in vitro using rat or human blood (t1/2: 3 and 4-12 min, respectively). Bio-
transformation of tert-butyl acetate in vitro is far more slowly (t1/2: 270-300 min).
Acetic acid is oxidised via the citric acid cycle to carbon dioxide and water.
Generally, the butanols are readily metabolised by alcohol and aldehyde dehydro-
genases to their respective aldehydes or ketones, their acids, and finally to carbon
dioxide, except for tert-butanol which is a very poor substrate for the dehydro-
genases and is metabolised only slowly. Ethanol inhibits or retards metabolism of
butyl acetates.
Parent compounds and metabolites were identified in urine or exhaled breath.
The committees could not retrieve any studies on methods for biological moni-
toring.
6. Effects
6.1 Observations in man
6.1.1 Irritation and sensitisation
n-Butyl acetate: In a volunteer study, the majority of the subjects (n=10)
experienced exposure to approximately 970 mg/m3 (200 ppm) for three to five
minutes to be irritating to the throat and exposure to 1,450 mg/m3 (300 ppm) to be
irritating to the nose and the eyes (and severely to the throat) (81). The extent of
irritation was scored subjectively based on three categories: not, slightly and very.
The results of a recent Swedish study on irritation effects on human volunteers
without previous occupational solvent exposure were published by Iregren et al.
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(61). Three experiments with different exposure levels were reported: 1) four
20-minute sessions with 24-hour intervals with 350, 700, 1,050 and 1,400 mg/m3
(72, 145, 217 and 290 ppm) (n=24); 2) two 20-minute sessions, 7 days apart, with
70 and 1,400 mg/m3 (14 and 290 ppm) (n=23); and 3) two 4-hour exposures with
a 7-day interval and exposure concentrations of 70 and 700 mg/m3 (14 and
145 ppm) (n=12). To evaluate the irritation produced by exposure to n-butyl
acetate, ten-point rating scales (from 0 ‘not at all’ to 9 ‘very much’) for perceived
irritation (eyes, throat, nose, skin, breathing difficulties, smell) and for CNS
effects (headache, nausea, etc), various measures of eye irritation, and pulmonary
function tests were used. The results show only a very low level of irritation from
these exposures as revealed by categorical ratings (mean ratings were at the
extreme lower part of the scale), magnitude estimation, and some of the clinical
measures of eye irritation and pulmonary functions, such as eye redness, lipid
layer thickness, and bronchial responsiveness. Thus, exposure to the highest
concentrations tested (i.e. 1,400 mg/m3 for 20 min and 700 mg/m3 for 4 h) caused
only minimal irritation to the eyes and respiratory tract (61).
In a study aiming at the development of test procedures for assessing individual
sensitivity to smells and chemicals, by exploring reactions to low-level chemical
challenge, two groups of male subjects with a different degree of solvent-induced
toxic encephalopathy and one previously unexposed, age- and education-matched
male reference group (n=12/group) were all exposed for two hours, starting after a
clean-air exposure of 20 minutes, at 14 mg/m3 which was gradually increased to
228 mg/m3 (appr. 3-48 ppm). At each exposure level, smell intensity (on a 7-step
category scale), mucous membrane irritation and annoyance reactions (on visual
analogue scales), and fatigue were scored. Generally, the groups with toxic ence-
phalopathy experienced significantly more irritation than the control group (88).
However, since an unexposed control group was not included, the committees
cannot draw conclusions from this study with respect to (no)-effect levels for
irritation.
n-Butyl acetate (4% in petroleum), or as a nail enamel containing 25.5% n-butyl
acetate, was reported to score negative in repeated insult patch tests, cumulative
irritation tests, and a clinical use study. The North American Contact Dermatitis
Group has listed butyl acetate as a dermatitis-causing ingredient identified by
patch test (one cutaneous reaction in 149 patch-tested patients) (110).
In a penicillin factory, a worker developed allergic contact dermatitis (eczema
of the hands, arms, and face). Patch testing revealed a positive reaction to butyl
acetate (5% in olive oil) (93). The committee assumes that with butyl acetate is
ment n-butyl acetate, because so far known in this kind of industry only n-butyl
acetate is used.
Isobutyl acetate: Isobutyl acetate (2% in petroleum) scored negative in a 48-hour
closed-patch test and in a maximisation test with volunteers (data from an
unpublished report submitted to the Research Institute for Fragrance Materials,
Inc, Englewood Cliffs NJ, USA, cited in (86)).
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sec-Butyl acetate, tert-butyl acetat: The committees could not retrieve data on
sec- and tert-butyl acetate.
6.1.2 Systemic toxicity
n-Butyl acetate: In a study to determine whether performance in neurobehavioural
test deteriorates during subjectively annoying chemical challenge below known
thresholds among persons with toxic encephalopathy with subjective hyper-
sensitivity to chemicals, two groups of subjects with a different degree of solvent-
induced toxic encephalopathy and one reference group (n=12/group) were
exposed to n-butyl acetate according to the schedule presented by Ørbæk et al.
(see (88), Section 6.1.1). Tests, measuring attention (digit symbol test) and motor
speed (simple and complex reaction-time task), were given at three occasions
throughout the exposure period, i.e. at the initial phase when exposure was to
clean air, after 40 minutes when the concentration was 56 mg/m3 (12 ppm;
duration 20 min), and after 70 minutes when the concentration was 228 mg/m3 (48
ppm; duration 20 min). This exposure scenario did not result in a detoriated
performance in the applied tests in any of groups of subjects (89).
Isobutyl, sec- and tert-butyl acetate: No case-control or epidemiological studies
were found in which systemic effects could be attributed to exposure to butyl
acetate.
6.2 Animal experiments
The reports of studies on the toxicity of butyl acetate isomers were almost entirely
limited to n-butyl acetate.
6.2.1 Irritation and sensitisation
n-Butyl acetate: Primary skin irritation of n-butyl acetate was tested using rabbits.
Following application of 0.01 mL of the undiluted ester to the clipped skin of five
albino rabbits, butyl acetate scored as a grade 1 irritant, i.e. giving rise to ‘the least
visible capillary injection’. This was the severest reaction of the skin within
24 hours following application (103). When a 0.5 mL dose was applied to the
clipped intact dorsal skin of New Zealand White Rabbits (n=5) under gauze
patches and loosely covered with impervious sheeting for four hours, no irritation
was observed according to Draize readings for up to fourteen days (primary
irritation index: 0.0/8.0). Severe irritation occurred following a 24-h occlusion
period (observation time: up to 14 days) (27, 77).
Guinea pigs showed signs of eye irritation at exposure to approximately
16,000 mg/m3 (3,300 ppm) n-butyl acetate, for five minutes (98). Exposure to
2,420 mg/m3 (500 ppm) for ten (guinea pigs) or twenty (rabbits) days, or to
4,840 mg/m3 (1,000 ppm) for four days (guinea pigs, rabbits) did not result in
corneal or conjunctival injury or in changes in corneal sensation (9). The degree
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of corneal necrosis was reported after instillation of various volumes and
concentrations of the liquid chemical into the eyes of rabbits. Following
instillation of 5 µL of the undiluted compound, butyl acetate was scored as a
grade 5 irritant (i.e. causing a ‘severe burn’). It was not stated whether the eyes
were rinsed with water after application of the test substance (103).
When tested according to OECD Guideline 405 (acute eye irritation/corrosion),
instillation of 0.1 mL of n-butyl acetate (purity: 99%) into the conjunctival sac of
4 rabbits resulted in a maximum Draize score of 7.50 (observation time: 24 h; at
48 h: 2.0; at 72 h: 2.0; at 7 d: 0.5 (45)). In another study, a maximum mean Draize
score of 14.7 was reported occurring at t=4 h (n=6; dose: 0.1 mL; observation
period: 21 d). Iritis and minor to moderate conjuctivitis (all healed within 48 h),
but no corneal injury were observed (27, 77). Kennah et al. reported Draize scores
of 8, 11, 19, and 2 following instillation of 100, 30, 10, and 3%, respectively
(observation time: 24 h) (66).
n-Butyl acetate was not a sensitiser when tested in the classical maximisation
test using guinea pigs, and in an alternative test, i.e. the mouse ear swelling test
(50).
With respect to the respiratory tract, the sensory irritation in the upper part was
studied by determining the concentration associated with a 50% decrease in the
respiratory rate (RD50). Using Swiss OF1 mice (n=probably 10), the RD50 for n-
butyl acetate was approximately 3,470 mg/m3 (720 ppm; (75), see also (26)). In a
separate study using male Balb/C mice (n=8-10), an RD50 of approximately
8,340 mg/m3 (1,726 ppm) has been determined (67).
In a thirteen-week inhalation study using rats, olfactory epithelial necrosis of
minimal to mild severity was found after exposure (6 h/day, 5 days/week) to 7,260
and 14,520 mg/m3 (1,500, 3,000 ppm), but no such lesions were observed at
exposure to 2,662 mg/m3 (550 ppm) (see Section 6.2.3 (10, 102)).
Isobutyl acetate: Isobutyl acetate has been tested for skin and eye irritation, but
not according to current standardised methods. The primary skin irritating
properties of isobutyl acetate were tested in rabbits. The compound was found to
be not irritating to the uncovered rabbit belly (scoring grade 1 on a scale of 1-10
within 24 hours following uncovered application of 0.01 mL of undiluted sample)
(104). After full strength application to intact or abraded rabbit skin under
occlusion for 24 hours, it was scored as moderately irritating (data from an
unpublished report submitted to the Research Institute for Fragrance Materials,
Inc, Englewood Cliffs NJ, USA, cited in (86)).
The ocular irritation of isobutyl acetate was evaluated in rabbits. Undiluted test
substance (0.5 mL) was found to cause a moderate inflammation to the eye (grade
2 on a scale of 1-10) (104).
With respect to respiratory tract irritation, an RD50 of 3,890 mg/m
3 (≈ 800 ppm)
has been found in mice (see also n-butyl acetate (75), see also (26)).
sec-Butyl acetate, tert-butyl acetate: No data are available on irritation and
sensitisation by sec-butyl acetate.
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Concerning tert-butyl acetate, primary skin irritation of this isomer was tested
by applying 0.5 mL of the test compound to the clipped intact dorsal skin of New
Zealand White rabbits (n=3/sex) under gauze patches semi-occlusively wrapped
with plastic, for four hours. Thereafter, wrappings were removed, residual test
compound washed off with distilled water, and scored for dermal irritation accor-
ding to Draize readings at 30-60 minutes and 24, 48, and 72 hours following patch
removal. Very slight, barely perceptible erythema (score 1 on a scale of 0-4) was
observed in 6/6, 4/6, 0/6 and 0/6 animals at 30-60 minutes, 24, 48 and 72 hours,
respectively. Oedema was absent at all observation intervals. No ulceration,
necrosis, or any other evidence of tissue destruction was seen at any of the
observation intervals (4).
The primary eye irritation of tert-butyl acetate was tested by instilling 0.1 mL
into the conjunctival sac of one eye of male New Zealand White rabbits (n=6).
Treatment induced corneal opacity in 1/6 (cleared by day), iritis in 3/6 (cleared by
day 2), and conjunctival irritation in 6/6 animals (cleared by day 3) and resulted in
mean Draize scores of 14.5, 6.8, 2.0 and 0 at observation times of 1 hour and 24,
48, and 72 hours, and 7 days, respectively (35). In another study, instillation of
0.1 mL into the conjunctival sac of 5 New Zealand strain albino rabbits only
caused minimal conjunctival irritation lasting for 96 hours. Mean Draize scores
were 4.8, 3.6, 2.0, 2.0, 1.6, and 0 at observation times of 1 hour, 24, 48, 72, 96
hours and 7 days, respectively (65).
Tert-butyl acetate did not act as a skin sensitiser in a delayed contact dermal
sensitisation test (Buehler method). Ten male Hartley Albino guinea pigs received
a topical induction application of the test compound at a concentration of 100%,
for three weeks (once/week). Skin reactions were recorded 24 and 48 hours
following each application. Two weeks after the first application, animals were
challenged with undiluted compound, and skin reactions were recorded at 24, 48
and 72 hours following the challenge dose. During the induction phase, no
erythema was found apart from very faint reactions in one animal 24 and 48 hours
after the first application, in two animals 24 hours after the second application,
and in one animal 24 hours after the third application (all different animals). Upon
challenge, no erythema was seen at any of the observations times except for a very
faint reaction in one animal at 24 hours (58).
With respect to tert-butyl acetate, only one study on respiratory tract irritation
has been found. The RD50 was ≈76,000 mg/m3 (≈15,750 ppm) (see also n-butyl
acetate (75), see also (26)).
6.2.2 Toxicity due to acute exposure
n-Butyl acetate: Data on the lethal toxicity following acute inhalatory exposure to
n-butyl acetate are summarised in Table 3.
The results from LC50 studies in rats show that exposure to nearly saturated
atmospheres generated by evaporation did not result in mortality. The data from
atmospheres/aerosols generated by atomisers are highly inconsistent ranging from
17
Table 3. Effects on experimental animals due to acute inhalatory exposure to n-butyl
acetate.
species concentration   duration      effect remarks ref.
rat   800 mg/m3
 2,200 mg/m3
 5,200 mg/m3
4 h
4 h
4 h
  6/10 dead
10/10 dead
10/10 dead
(n=5/sex/group) head-only; dynamic
inhalation system; atomiser
LC50 =740 mg/m
3
32
rat 32,000 mg/m3
29,200 mg/m3
13,890 mg/m3
 9,345 mg/m3
4 h
4 h
4 h
4 h
  0/10 dead
  0/10 dead
  0/10 dead
  0/10 dead
(n=5/sex/group) whole body;
statically generated, nearly saturated
vapour
(n=5/sex) whole body; dynamic
inhalation system;
evaporation
LC50 >32,000 mg/m
3
78
rat  1,305 mg/m3
 2,490 mg/m3
4 h
4 h
  0/10 dead
10/10 dead
(n=5/sex/group) whole body;
dynamic inhalation system; atomiser
LC50 =1,800 mg/m
3
78
rat 4,990 mg/m3 4 h   0/10 dead head only; dynamic inhalation
system; atomiser
14
rat 21,395 mg/m3 4 h   0/10 dead head-nose only; dynamic inhal.
system; atomiser
15
rat 2,005 mg/m3
21,395 mg/m3
4 h
4 h
  0/10 dead
  0/10 dead
head-nose only; dynamic inhal.
system; atomiser
16
rat 21,395 mg/m3 4 h   0/10 dead head-nose only; dynamic inhal.
system; evaporation
17
rat 3,990 mg/m3
 5,730 mg/m3
 5,790 mg/m3
 6,560 mg/m3
4 h
4 h
4 h
4 h
  3/10 dead
  5/10 dead
  6/10 dead
  9/10 dead
(n=5/sex/group) whole body;
dynamic inhalation system; atomiser
LC50 =5,055 mg/m
3
79
rat  3,680 mg/m3
 6,505 mg/m3
 6,650 mg/m3
 6,995 mg/m3
 7,260 mg/m3
23,430 mg/m3
42,930 mg/m3
 6,980 mg/m3
 7,140 mg/m3
4 h
4 h
4 h
4 h
4 h
4 h
4 h
4 h
4 h
  0/10 dead
  0/10 dead
  0/10 dead
  0/10 dead
  0/10 dead
  0/10 dead
  0/10 dead
  0/10 dead
  0/10 dead
(n=5/sex/group) whole body;
dynamic inhal. system; different
atomisers under varying conditions
(pressure, humidity) testing new and
old (latter two data) production
material
LC50 >42,930 mg/m
3
80
rat 9,700 mg/m3 4 h LC50 82
mouse 6,000 mg/m3 2 h LC50 82
guinea
pig
16,000 mg/m3
33,000 mg/m3
67,000 mg/m3
5 min
13.5 h
6 h
11.7 h
15-30 min
4 h
irritation
no other effects
incoordination
narcosis
narcosis
dead
98
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740 mg/m3 (160 ppm) to above 42,930 mg/m3 (9,312 ppm). After an LC50 of 740
mg/m3 (160 ppm) was reported for aerosolised n-butyl acetate in a study (32), six
follow-up studies were conducted at three different laboratories in order to
replicate the data, to differentiate between data from vapours and aerosols, and to
investigate the role of small particles and of relative humidity (unpublished
studies reviewed in (85)). The LC50 values for aerosolised n-butyl acetate deter-
mined in these studies were all statistically significantly different and increased
with time. These inconsistencies occurred not only between laboratories, but also
within the same laboratory. Using identical inhalation equipment and aerosol
generation procedures, one laboratory observed no mortality at concentrations up
to approximately 21,395 mg/m3 (4,429 ppm). In the second laboratory, experi-
ments resulted in LC50s of approximately 1,800 mg/m
3 (390 ppm) and
5,055 mg/m3 (1,096 ppm), while no mortality occurred in the third experiment at
exposure up to 42,930 mg/m3 (9,312 ppm). In the third laboratory, findings not
observed in any of the other two laboratories included low chamber relative
humidity, brief times to death (all deaths within 24 hours post-exposure, 7/10
animals of the highest concentration group died in the last 2 h of exposure vs
mortality 1 to 4 days post-exposure in the other studies), and the histological
finding of vesicular emphysema, suggesting that there might have been methodo-
logical problems in this study. Overall, Norris et al. (85) could not find explana-
tions for inconsistent results from exposure to aerosolised n-butyl acetate.
Clinical signs observed in rats during these experiments ranged from eye
irritation (periocular wetness, blepharospasms) to nervous system effects (hypo-
activity, ataxia, forced/shallowed breathing, narcosis). At gross necropsy in the
deceased animals, discoloration of the lungs and fluid in the thoracic cavity and
trachea were observed. Microscopical examination performed on some of the
lungs showed congestion, alveolar haemorrhage, sloughing of bronchiolar
mucosa, necrosis of alveolar epithelial cells, and oedema (78, 79). Discoloration
of the lungs was also observed in rats surviving exposure to approximately 23,000
and 43,000 mg/m3. In this study, no clinical signs were observed during the 14-
day after exposure period, and only the highest exposure level produced clinical
signs (narcosis, incoordination, perioral wetness), that were still present on the
same day shortly following exposure. Exposure concentrations of 3,680 to
7,260 mg/m3 caused blepharospasms (80).
A study, investigating the effects on the nervous system following acute
exposure, has been conducted with n-butyl acetate vapours generated by evapo-
ration. Measurements indicated that the test compound was not present in aerosol
form. Based on the results of a range finding study, four groups of twenty rats
(n=10/sex) were exposed to 0 and 7,260, 14,520, and 29,040 mg/m3 (0, 1,500,
3,000, 6,000 ppm) for six hours. Deaths and clinical signs were not noted. During
exposure, reduced activity and reduced response to stimuli (tapping on the
chamber) were observed in all dose groups ranging from minimal in the low dose
group to minor to moderate in the high dose group. These observations were
subjective and incomplete, since they include only those animals that were visible
through the inhalation chamber windows. Motor activity measured in ten-minute
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intervals during a 60-minute period (30 min after ending exposure, and on
postexposure days 1, 7, 14) was transiently (i.e. not on the postexposure days)
reduced in the mid and high dose groups. The functional observational battery
examinations (1.5 h after ending exposure, and on postexposure days 7, 14)
showed no effects on motor activity in the open field. Effects were observed
directly after exposure only and included slightly unkempt hair coat in the high
dose group and increased forelimb grip strength for the female animals of the mid
dose group. Differences in mean body weights (decreases) between treated and
control animals did not exceed 10%, but were statistically significant for the male
animals of the low (on postexposure day 7) and high dose (on postexposure days 7
and 14) groups (21).
In a separate study, the effects of exposure to vaporised n-butyl acetate on the
behaviour of Wistar rats have been tested using the rotarod performance and the
hot plate test (10 rats/group; exposure time: 4 h; testing immediately after ending
exposure). All animals survived, which might imply that they may have sustained
four-hour exposures of up to approx. 49,000 mg/m3 or 10,000 ppm. The ED50 for
the rotarod performance (i.e. the concentration at which 50% of the animals did
not succeed in remaining on the rotating rod for 2 min) was calculated to be
approximately 35,900 mg/m3, while the ED50 for the hot plate test (i.e. the
concentration at which the latency of the paw-lick response was increased by 50%
when compared with the response under control conditions) was approximately
28,000 mg/m3 (67).
Data, on mainly lethality, following single exposure to n-butyl acetate by other
routes are summarised in Table 4. They indicate that n-butyl acetate is not very
toxic via oral, ip, or dermal administration.
Table 4. Effects on experimental animals after single exposure to n-butyl acetate.
species dose route effect ref.
rat, male 14.5 mL/kg bw oral LD50 27, 77
rat, female 12.2 mL/kg bw oral LD50 27, 77
rat 14.1 g/kg bw oral increase in serum ornithine 103
mouse 7.1 g/kg bw oral LD50 82
mouse   1.2 g/kg bw ip LD50 82
rabbit   2.2 g/kg bw oral ND50
a 76
rabbit   7.7 g/kg bw oral LD50 76
rabbit, male and female 16.0 mL/kg bw dermal no deaths 27, 77
guinea pig 1 mL/3.1 cm2 dermal no pathological changes in the
skin. No alterations in
morphology of liver and
kidneys.
69
guinea pig 1.5 g/kg bw ip LD50 42
guinea pig 750 mg/kg bw ip carbamyl transferase activity 42
aND50: the quantity that produced stupor and loss of voluntary movements on half of the animals.
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Table 5. Effects on experimental animals after acute or single exposure to isobutyl
acetate
species conc./dose duration route effect reference
rat
rat
rat
rat
rabbit
rabbit
rabbit
  38.9 g/m3
  14.0 g/m3
100.0 g/m3
  13.4 g/kg bw
  15.0 g/kg bw
    4.3 g/kg bw
    4.8 g/kg bw
>20.0 g/kg bw
 4    h
 6    h
 2.5 h
 -
 -
 -
 -
 -
inhalation
inhalation
inhalation
oral
oral
oral
oral
dermal
4/6 animals died
No toxicity symptoms
LD100
LD50
LD50
ND50
a
LD50
LD50
104
25
25
104
104
76
82
82
aND50: the quantity that produced stupor and loss of voluntary movements on half of the animals.
Isobutyl acetate: Data, on mainly lethality, following acute and single exposure to
isobutyl acetate are presented in Table 5. They indicate that isobutyl acetate is not
very toxic via the inhalatory, oral, or dermal route.
sec-Butyl acetate and tert-butyl acetate: All rats survived exposure to approxi-
mately 17,000 mg/m3 (3,500 ppm) of sec-butyl acetate, for six hours, while all rats
died when exposed to 116,000 mg/m3 for four hours. An oral LD50 of 3,200-6,400
mg/kg bw was reported for rats (unpublished data; no more details available) (95).
For tert-butyl acetate, a four hour LC50 of 13,300 mg/m
3 has been determined
for rats by exposing the animals (Sprague-Dawley; n=5/sex/group) to aerosol
concentrations of 5,000, 10,000, 15,000 or 30,000 mg/m3 (particle size and
distribution not given). Generally, the time course of clinical signs during the
exposure period was similar at all concentrations, but the onset of the effects was
much shorter at the higher concentrations. Symptoms observed included inactivity
and sedation, hyperactivity, comparable to the excitation state of anaesthesia,
coma, and death. Post-mortem examination showed some evidence of pulmonary
congestion and haemorrhage only (observation time 14 days) (65). In another
study, all rats (Harlan Sprague-Dawley; n=5/sex) survived nose-only exposure to
a mean vapour concentration of 2,230 mg/m3 (470 ppm), for four hours. Apart
from slight weight loss between days 0 and 7 in one female and red penile dis-
charge in one male animal, no abnormalities were observed upon body weight, in-
life, and gross necropsy observations (observation time 14 days) (19).
No mortality or effects on body weight were found in New Zealand White
rabbits (n=5/sex/group) following application of a single dose of 2,000 mg/kg bw
to the clipped intact dorsal skin under gauze patches wrapped with plastic, for 24
hours. Apart from instances of diarrhoea in 3/10 animals during the first week of
fourteen days, no dermal responses (erythema or oedema) were observed during
and at the end of the observation period. Apart from kidney abnormalities in one
female animal, no abnormalities were observed upon post-mortem macroscopic
examination (36). Only erythema (not indicated at which single doses) dis-
appearing within 48 hours was reported following 24-hour, covered application of
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five single doses ranging from 2.0 to 23.0 mL/kg bw (±1,800-20,700 mg/kg bw)
to the clipped skin of New Zealand strain albino rabbits (n=2/sex/group)
(observation time 14 days) (65).
An oral LD50 of 3.8 mL/kg bw (±3,420 mg/kg bw) was estimated in rats
(Sprague-Dawley; n=5/sex/group) by using eight dose groups and a dose range of
1.0 to 12.0 mL/kg bw. At 1.0 mL/kg bw, only a slight restlessness was observed.
At doses of 2.0 mL/kg bw and higher, initial restlessness was followed by ataxia,
coma and death. Severeness and incidence of effects increased and time of onset
of effects decreased with increasing doses. No gross histological changes were
observed in the tissue and organs of the dead animals at post-mortem examina-
tions (observation time 14 days) (65). In a separate study, oral administration of
2,000, 5,000 or 7,000 mg/kg bw to Wistar rats (n=5/sex/group) resulted in a LD50
of 4,500 mg/kg bw (males: 4,100 mg/kg bw; females: 4,750 mg/kg bw). Clinical
signs observed included ataxia, flaccid muscle tone, lethargy, dyspnea, loss of
righting reflex, prostration, piloerection, tremors, and coma. Necropsy findings in
the surviving animals were normal, while in the treatment-related deaths there
were abnormalities in various organs as well as wetness and red and brown
staining of the nose and mouth area (37).
6.2.3 Toxicity due to short-term exposure
n-Butyl acetate: Data on toxicity due to short-term exposure to n-butyl acetate are
mostly from very old studies (before 1940). In guinea pigs, exposure to 4,840
mg/m3 (1,000 ppm) n-butyl acetate, 4 h/day, for 28 days did not have effects on
blood counts, urine examinations or necropsy data (9).
Cats exposed to approximately 20,000 mg/m3 (4,140 ppm) of n-butyl acetate,
6 h/day, for 6 days showed weakness, weight loss, and minor changes in blood
values. At approximately 15,000 mg/m3, changes in blood cell morphology were
observed and at 7,600 mg/m3 increased salivation (9).
In a study conducted to select exposure concentrations for a subsequent thirteen-
week studies (see below), male and female Sprague-Dawley rats were exposed to n-
butyl acetate vapour of ± 0, 3,630, 7,260 and 14,520 mg/m3 (0, 750, 1,500 and
3,000 ppm), 6 h/day, 5 days/week for two weeks. Each exposure group consisted of
five male and five female ad libitum-fed animals and five feed-restricted male
animals. Treatment induced concentration-related reductions in activity levels
(hypoactivity; reduced responses to extrachamber stimulation). In the 3,630 mg/m3
exposed group, reductions were of minimal to minor severity at the beginning and
absent by the end of the week. In the 7,260 mg/m3 exposed group, severity de-
creased from minor to minimal over the course of the week, while it remained
minor in the 14,520 mg/m3 exposed group. Other occasional signs noted were
sialorrhea in 4/15 and 8/15 animals of the 7,260 and 14,520 mg/m3 exposed group
respectively, and red sialorrhea, porphyrin tears and nasal discharge, brown-
discoloured facial hair, and unkempt haircoat in individual animals of the
14,520 mg/m3 exposed group. There was no apparent difference in these clinical
signs between ad libitum-fed and feed-restricted animals. Apart from two animals
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of the feed-restricted 14,520 mg/m3 exposed group, animals in all treated groups
were normal after exposure. Further, treatment did not affect performance in an
abbreviated functional observational battery (FOB) after the final exposure. Some
effects on mean body weights were observed (decreases in the female animals of
the 7,260 mg/m3 exposed groups and in the male and female animals of the
14,520 mg/m3 exposed group), but only in the male animals of the feed-restricted
14,520 mg/m3 exposed group, a statistically significant decrease in mean terminal
body weight and in mean body weight gain was observed. At necropsy, there were
no effects on absolute or relative lung, kidney, or liver weights or histological
changes (22).
In a thirteen-week inhalation study, conducted in parallel with a subchronic
neurotoxicity study (see below), male and female Sprague-Dawley rats
(n=15/sex/group) were exposed to target vapour concentrations of approximately
0, 2,662, 7,260, and 14,520 mg/m3 (0, 550, 1500, 3000 ppm), 6 h/day,
5 days/week, for thirteen to fourteen weeks. During exposure, clinical observa-
tions, body weight recordings, and feed consumption determinations were made
regularly. Furthermore, effects on mortality, ophthalmology, haematology, and
clinical chemistry parameters, organ weights, and gross and microscopical
histology were evaluated. On day 30, five animals/sex/group were killed for
clinical pathology. There was no compound-related mortality in any of the groups.
In the 14,520 mg/m3 exposed group, all animals showed reduced activity (defined
as less movement, decreased alertness, and slower response to tapping on the
chamber wall in comparison with control animals) of minor severity. Occasio-
nally, signs of sialorrhea and red discoloration on the chin hair were observed.
Mean body weights and food intake were statistically significantly lower than
those of the control animals almost throughout the study. Overall, weight gains for
males and females were respectively 38 and 22% lower than those for controls.
There were no treatment-related ophthalmological changes or biologically or
toxicological relevant effects on haematological or clinical chemistry parameters.
Organ weight changes included, amongst others, decreased absolute liver and
kidney weights, decreased absolute and relative spleen weights (males), and
increased relative adrenals and lung weights (males). Upon macro- and micro-
scopical examination, lesions found were limited to the stomach (minimal
haemorrhage in the glandular gastric mucosa in 2/10 females; minimal white
discoloration in the non-glandular gastric mucosa in 1/10 females; minimal to
mild inflammatory and degenerative lesions of stomach mucosa in 3/10 females)
and the nasal passages (olfactory epithelial necrosis of mild to moderate severity
in all males and females). There was no effect on epididymal or testicular sperm
counts. In the 7,260 mg/m3 exposed group, all animals exhibited reduced activity
of minimal severity. Mean body weights were statistically significant lower at
week 6 onwards for male and at week 2 onwards for female animals. Overall,
weight gains were approximately 20-30% lower than those for controls. Food
intake was generally lower throughout the study. There were no effects on
ophthalmology, haematology, or clinical chemistry parameters. Organ weight
changes observed were, amongst others, decreased absolute spleen, liver, and
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kidney (females) and increased relative adrenal (females) weights. Upon macro-
and rnicroscopical examination, only histological lesions in the nasal passages
consisting of olfactory epithelial necrosis of minimal to mild severity in 4/10 male
and 3/10 female animals were observed. There was no effect on epididymal or
testicular sperm counts. In the 2,662 mg/m3 exposed group, no treatment-related
effects were observed (23).
A neurotoxicity study was conducted in compliance with an Enforceable
Consent Agreement, as outlined in the Testing Consent Order (see Fed Reg 1995;
60: 4516-20; January 23), negotiated with USEPA in accordance with the Toxic
Substances Control Act (TSCA) and conforming USEPA’s most recent relevant
guidelines. Male and female Sprague Dawley rats (n=30-40/group) were exposed
to 0, 2,662, 7,260, and 14,520 mg/m3 (0, 550, 1,500, 3,000 ppm), 6 h/day,
5 d/week, for 13-14 weeks. End-points were functional observational battery
(FOB) and motor activity (during week 1-13 in 10-15 animals/sex/group),
neuropathology (gross and microscopic examination of -sections from- the brain,
spinal cord, dorsal and ventral spinal roots, dorsal root ganglia, sciatic nerve, and
tibial nerve at study termination in 5 animals/sex/group), and scheduled-
controlled operand behaviour (SCOB) (during exposure and two weeks post-
exposure in 10 feed-restricted male animals/group). Body weights were recorded
regularly. Clinical observations were made through the inhalation chamber
windows during exposure, and further before and after exposure and during
performing FOB. In the ad libitum-fed animals of the 14,520 mg/m3 exposed
groups, treatment caused lower mean body weights throughout the study resulting
in an overall decrease of 15-19% and lower mean body weight gains for males
throughout the study and for females during the first six weeks resulting in an
overall decrease of 36-41%. Exposure to 14,520 mg/m3 further induced signs of
sialorrhea, gasping, and red discoloration of the chin, as well as reduced activity
of minor severity. In the 7,260 mg/m3 exposed group, no effects were observed on
body weights of the male animals, while those of females were lowered from
week 6 onwards (overall decrease 9%). Mean body weight gain was affected
occasionally (male, week 9, 14; female, week 6, 11) with an overall decrease of
16-26%. In addition, reduced activity of minimal severity was observed. No such
effects were observed in the group exposed to 2,662 mg/m3. No treatment-related
effects indicative of neurotoxicity were observed in the FOB, motor activity,
SCOB, and gross and microscopic examinations in any of the exposure groups.
No signs of toxicity were observed at in situ observation of abdominal and
thoracic organs (24), see also (31).
Iso-, sec- and tert-butyl acetate: No data found.
6.2.4 Toxicity due to long-term exposure and carcinogenicity
No data were found on long-term toxicity or carcinogenicity studies on butyl
acetates.
24
Table 6. In vitro genotixicity tests with n-butyl acetate.
test system endpoint test concentrations resulta ref.
S. typhimurium:
TA100/-1535/-1537/-98/-97
TA100/-1535/-1537/-98/-1538
TA100/-1535/-1537/-98/-94/-92
gene mutation
gene mutation
gene mutation
    33-10,000 µg/plate
      1-  5,000 µg/plate
up to 10,000 µg/plate
-/-
-/-
-/-
92
101
62
E.coli WP2 uvrA gene mutation       1-  5,000 µg/plate -/- 101
S.cerevisiae D61.M mitotic aneuploidy        0.25-0.4% -/nt 92
Chinese hamster fibroblasts chrom. abberations
polyploidy
  up to 2,000 µg/plate -/nt 62
aResults of tests without/with a metabolic activation system respectively; - = negative result;
nt = not tested.
6.2.5 Genotoxicity
n-Butyl acetate was adequately tested at sufficiently high concentrations in
bacteria (S. typhimurium, E. coli), yeast (S. cerevisiae), and in one mammalian
cell system (Chinese hamster fibroblasts) (see Table 6). In all these systems,
negative results were obtained. There were no data from in vivo tests.
No data are available on mutagenicity of the other butyl acetate isomers.
6.2.6 Reproduction toxicity
The reproduction toxicity of n-butyl acetate has been evaluated in rats and rabbits
(55). Rats (n=37-42/group) were exposed to 0 or 7,260 mg/m3 (1,500 ppm),
7 h/day, during GD7-16 (group 2), during GD1-16 (group 3), or pregestationally
for three weeks (5 days/week) and subsequently during GD1-16 (group 4). The
animals of all groups were mated with unexposed male rats. Mating and repro-
ductive performance (pregnancy rates, numbers of corpora lutea, implantation
sites, resorptions, live foetuses per litter) were not affected by treatment. During
exposure, a statistically significant decrease in food intake was observed in all
exposure groups. Maternal toxicity, including decreased body weight (p<0.01)
and decreased absolute liver (p=0.01), and increased relative kidney and lung
weights (p=0.03 and 0.01, respectively), was observed in all exposure groups.
Signs of minor developmental toxicity were observed. In all exposure groups,
foetal growth (body weight, crown-rump length) was statistically significantly
reduced. Increased incidences of rib dysmorphology and reduced pelvic ossifica-
tion were observed in group 2 (p=0.05 and 0.08, resp) and group 3 (p=0.07 and
0.002, resp). In addition, there was an increased incidence of hydroureter in group
4 (p=0.05).
Groups of rabbits (n=21-25/group) were exposed to 0 or 7,260 mg/m3
(1,500 ppm) n-butyl acetate, 7 h/day, during GD7-19 (group 2) or 1-19 (group 3).
No effect on maternal body weights was found, but in both exposure groups
absolute organ weights (kidney, spleen, lung) were statistically significantly
increased. Increased incidences in minor developmental effects including retinal
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folds (p=0.04), misaligned sternebrae (p=0.04), and morphological variations in
gallbladder (p=0.05) were noticed in group 3 (55).
The committees consider the results found in these reproduction tests incon-
clusive, because only one concentration was tested. At that concentration, both
maternal and foetal effects were found. The committees cannot exclude that these
foetal effects are caused by effects on the mother.
No data were available on sec- and tert-butyl acetate.
6.3 Summary
6.3.1 Human data
n-Butyl acetate is only minimally irritating to the eyes and respiratory tract of
volunteers exposed to 700 mg/m3 (≈145 ppm) for four hours. It may occasionally
cause allergic contact dermatitis. Isobutyl acetate probably has no sensitising
properties.
No case-control or epidemiological studies were found in which systematic
effects could be attributed to exposure to butyl acetate.
6.3.2 Animal data
Under not-occluded conditions n-butyl acetate has no skin irritant properties and it
has not shown to be a sensitiser. The committees consider n-butyl acetate at most
slightly irritating to the eyes of rabbits. Tert-butyl acetate is a very slight eye and
skin irritating compound, and has probably no skin sensitising properties.
Data from acute inhalatory exposure (parameter mortality) of n-butyl acetate
are conflicting, but n-butyl acetate as well as isobutyl acetate can be considered to
be of low toxicity via the inhalatory, oral, and dermal route. Exposure to n-butyl
acetate levels of ≈3,700-7,300 mg/m3 (≈800-1,575 ppm) for four to six hours
result in transient effects on the eyes and behaviour of rats.
Subchronic exposure for 13 weeks (6 h/day, 5 days/week) to up to ≈ 14,520
mg/m3 (3,000 ppm) n-butyl acetate did not induce persistent neurotoxic effects in
rats. Exposure to ≈7,260 mg/m3 (1,500 ppm) caused decreased body weight gain,
reduced transient activity on the nervous system, and minimal to mild olfactory
lesions. From these data, the committees derive a NOAEL of ≈2,662 mg/m3
(550 ppm).
No valid data are available on systematic and carcinogenic effects following
chronic exposures. Furthermore, n-butyl acetate did not induce mutations in
bacteria and yeast nor did it induce clastogenic effects in Chinese hamster
fibroblasts.
In a developmental study in which rats and rabbits were exposed to approxi-
mately 7,260 mg/m3 (1,500 ppm) in a number of exposure schemes, minor
developmental effects in the presence of maternal toxicity were observed in both
species. Since this was the only level tested, and both maternal and developmental
toxicity were found, the committees consider the results of this study to be incon-
clusive.
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Data on short-term effects, carcinogenicity or genotoxicity and reproduction
toxicity of isobutyl, sec- and tert-butyl acetate are lacking.
7. Existing guidelines, standards and evaluations
7.1 General population
The Commission of the European Communities did not classify, and consequently
did not label, the butyl acetate isomers with respect to irritation and toxicity (29).
n-Butyl acetate as well as isobutyl acetate were given GRAS (generally
recognised as safe) status in 1965 by Flavouring Extracts Manufacturers’
Association, which were accepted by FDA for food use and were listed by the
Council of Europe with an ADI of 1 mg/kg (86, 87). However, according to a
recent publication by FAO/WHO, no ADI has been allocated and no toxicological
monograph has been prepared (108). No guidelines or standards for the general
population were found for n-butyl acetate, isobutyl acetate, sec-butyl acetate, and
tert-butyl acetate.
7.2 Working population
The occupational exposure limits for n-butyl acetate, isobutyl acetate, sec-butyl
and tert-butyl acetate in the Netherlands and some other countries are summarised
in Table 7.
ACGIH (USA)
ACGIH stated that the marked toxicity of the atomised n-butyl acetate observed in
animal bioassays (i.e. an LC50 of ≈750 mg/m3 (156 ppm) found in an acute
mortality study in rats) is not of practical concern in the workplace where
exposures to n-butyl acetate occur almost universally to the vapour. ACGIH has
recommended a TLV of ≈725 mg/m3 (150 ppm) for n-butyl acetate to minimise
the potential risk of eye and mucous membrane irritation reported in the studies by
Nelson et al. (81) and Iregren et al. (61) in volunteers exposed at ≈ 965 to
1425 mg/m3 for 3 to 20 minutes, and a STEL of ≈965 mg/m3 (200 ppm) to control
the excursions that produced mucous membrane irritation in the same studies. A
skin designation has not been assigned, because of the high vapour pressure and
the lack of systemic toxicity following topical application to rabbits and guinea
pigs (4).
With respect to isobutyl acetate, ACGIH concluded that the animal data on
acute toxicity indicate that isobutyl acetate is somewhat more toxic, but somewhat
less irritating than n-butyl acetate. In view of these data, an identical TLV of
≈725 mg/m3 (150 ppm) was recommended to minimise the potential for ocular
and respiratory tract irritation (3).
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Table 7. Occupational exposure limits in the Netherlands and some other countries.
country isomer level time remark ref.a
mg/m3 ppm TWA
The Netherlands n-
iso-
sec-, tert-
710
700
950
150
150
200
  8 h
  8 h
  8 h
administrative
force
109
Germany
- AGS
- DFG MAK-kom.
all
n-, iso-
sec-
tert-
950
950
480
960
      c
96
480
200
200
100
200
20
100
  8 h
15 min
  8 h
15 minb
  8 h
30 mind
 e
 e
28
41
Sweden all 500
700
100
150
  8 h
15 min
13
Denmark all 710 150   8 h 12
UK
- HSE n-
iso-
sec-, tert-
724
966
724
903
966
1210
150
200
150
187
200
250
  8 h
10 min
  8 h
10 min
  8 h
10 min
 OES
 OES
 OES
59
European U.
-SCOEL - -
60
USA
- ACGIH
- OSHA
- NIOSH
n-
iso-
sec-, tert-
n-
iso-
sec-, tert-
n-
iso-
sec-, tert-
-
-
-
-
710
700
950
710
950
700
950
150
200
150
200
150
150
200
150
200
150
200
  8 h
15 min
  8 h
  8 h
  8 h
  8 h
  8 h
10 h
15 min
10 h
10 h
 TLV
 STEL
 TLV
 TLV
 PEL
 PEL
 PEL
 REL
 STEL
 REL
 REL
6
5
5
aReference to the most recent official publication of OEL.
bMaximum frequency per shift, 4 (with an interval of 1 hour).
cListed among substances for which the toxicological data base was considered to be not
sufficient to derive an OEL.
dMaximum frequency per shift, 2.
eListed among compound for which there is no reason to fear a risk of damage to the developing
embryo or foetus when the OEL is observed.
ACGIH stated that there were no data on the toxicity of sec- and tert-butyl
acetate, and that there were no reports of harmful effects on workers either. It was
concluded that sec- and tert-butyl acetate were less irritating than n-butyl acetate,
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and that therefore a slightly higher TLV of ≈ 965 mg/m3 (200 ppm) could be
recommended for these isomers (1, 2).
Germany
In Germany, DFG concluded for n-butyl acetate that irritation of eyes, nose, and
throat is the critical effect due to occupational exposure. Data on irritation in
humans were concluded to be inconsistent, but urged the need for lowering the
occupational exposure limit which was subsequently set at 480 mg/m3 (100 ppm).
Based on the subchronic neurotoxicity inhalation study and data on the systemic
toxicity of its metabolite n-butanol, having a MAK-value of 100 ppm, it was
stated that n-butyl acetate is not expected to induce systemic effects at this level.
From data on the reproduction toxicity of n-butyl acetate and n-butanol, DFG
concluded that there would be no reason to fear a risk of damage to the developing
embryo or foetus when this occupational exposure limit is observed. The available
data did not indicate the need for assigning notations of danger of cutaneous
absorption or of sensitisation (52).
Concerning isobutyl acetate, DFG stated that irritation might be the critical
effect, but that there were no data on the relationship between doses and irritative
effects. However, it was assumed that there would be no significant difference in
the irritation potency of n- and isobutyl acetate, and, therefore, the occupational
exposure limit was set at 480 mg/m3 (100 ppm). Based on the data on the systemic
toxicity of the metabolite iso-butanol (MAK-value 480 mg/m3 (100 ppm)), DFG
did not expect such effects to occur or reason to fear a risk of damage to the
developing embryo or foetus when this occupational exposure limit is observed.
Because of lack of data no skin notation was assigned. The data available did not
indicate the need for assigning a notation of sensitisation (52).
Because of lack of data on local and systemic effects of sec-butyl acetate as
well as its metabolite sec-butanol, DFG withdrew the existing limit value and
listed sec-butyl acetate among substances for which the toxicological data base is
considered to be not sufficient to derive an occupational exposure limit (52).
For tert-butyl acetate, there were no relevant data on irritation or systemic
effects. According to DFG, irritation might be the critical effect, but systemic
effects due to the increasing presence of tert-butanol in the body following
inhalation exposure to tert-butyl acetate cannot be excluded. Since, based on
experimental animal systemic toxicity data, the limit value for tert-butanol is 96
mg/m3 (20 ppm), DFG decided to set the occupational exposure limit for tert-butyl
acetate at 96 mg/m3 as well. Analogous to tert-butanol, tert-butyl acetate was
listed among compounds for which pregnancy risk group classification was not
possible, because although the data available may indicate a trend they are not
sufficient for final evaluation. Because of lack of data, notations of danger of
cutaneous absorption or of sensitisation were not assigned (52).
CIREP (USA)
The US Cosmetic Ingredient Review Expert Panel (CIREP) concluded that n-
butyl acetate was mildly irritant to the skin of rabbits. It was mildly and
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moderately to severely irritant to rinsed and unrinsed rabbit eyes, respectively. It
had no sensitising properties when tested in guinea pigs and mice. n-Butyl acetate
was not teratogenic when inhaled by rats and rabbits at a concentration of ≈7,245
mg/m3 (1,500 ppm). It did neither induce mutations in S typhimurium nor mitotic
aneuploidy in yeast nor chromosomal aberrations in Chinese hamster fibroblasts.
When tested as an ingredient of cosmetic formulations, it was not a sensitiser in
humans and was at most mildly irritating. From these data, the CIREP concluded
that butyl acetate could be used safely as a cosmetic ingredient in the current
practices of use and concentration (110).
8. Hazard assessment
8.1 Assessment of health risk
n-Butyl acetate: The committees could not find case-control or epidemiological
studies in which systemic effects could be attributed to exposure to n-butyl
acetate. Only very minimal irritation was observed in volunteers exposed to 700
mg/m3 (145 ppm) for four hours, in a study designed to examine irritation from
exposure to organic solvent vapours, including n-butyl acetate, in an objective
way. Since butyl acetates are hydrolysed to their respective alcohols, data on
systemic toxicity induced by these alcohols may be of interest. However, in a
criteria document on n-, sec-, and tert-butanol, no relevant data on the systemic
toxicity of these alcohols could be presented (56).
There are no relevant data available from chronic, carcinogenicity and
reproduction toxicology animal studies, on which conclusions regarding
carcinogenicity and reproduction toxicity can be based. The committees conclude
that n-butyl acetate is not mutagenic in bacteria and yeast, nor clastogenic in a
mammalian cell system in vitro. In vivo data on mutagenicity are not available.
The committees find the varying results of the acute inhalatory studies,
particularly those in rats exposed to atmospheres generated by atomisers, difficult
to interpret. Although ACGIH suggested that the difference in toxicity might be
due to the difference in methods of generating atmospheres (i.e. evaporation vs
atomisation, or vapours vs aerosols (9)), the results from several studies with
atomised n-butyl acetate are already conflicting. In addition, it was demonstrated
that the concentrations of n-butyl acetate particulates in these experiments were
very low or virtually non-existing. Therefore, the mortality observed cannot be
attributed to the presence of aerosols. From the results of a recent well designed
and performed experiment, resulting in a LC50 exceeding 43,000 mg/m
3
(9,312 ppm (80)), the committees conclude that the toxicity of n-butyl acetate
following a single four-hour inhalation exposure is low. Furthermore, the
committees state that n-butyl acetate has a very low acute toxicity following oral
administration and dermal application.
In two other animal studies (21, 55), slight transient behavioural effects
(exposure duration 6 h), and effects on body weight, absolute liver and relative
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kidney and lung weights (exposure duration: 7 h/day, 10-31 days) were found in
rats following exposure to ≈7,260 mg/m3 (1,500 ppm).
Furthermore, two subchronic studies have been performed, in which rats were
exposed to 0, 2,662, 7,260 or 14,520 mg/m3 (0, 550, 1,500 or 3,000 ppm) n-butyl
acetate for 13 to 14 weeks (23, 24). Animals exposed to 7,260 mg/m3, showed
decreased mean body weight (9%, males), decreased mean body weight gain (16-
26%), decreased transient motor activity (nervous system) and minimal to mild
necrosis on the olfactory epithelium. There was no persistent neurotoxicity
following exposure up to 14,520 mg/m3. From these study results, the committees
conclude that both systemic and local effects do occur. From the subchronic study
of Bernard and David (23), the committees derived a NOAEL of 2,662 mg/m3
(550 ppm).
8.2 Groups at extra risk
No data are known that enables the identification of groups at extra risk.
9. Recommendations for research
The following studies are recommended for all four isomers:
• kinetic studies;
• 28-day inhalation toxicity studies (except for n-butyl acetate);
• reproduction toxicity studies;
• a respiratory and eye irritation test with human volunteers using exposure
periods long enough to determine no-adverse-effect levels for irritation.
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10. Summary
Stouten H, Bogaerts W. DECOS and SCG Basis for an Occupational Standard.
n-, iso-, sec-, and tert-Butyl acetate. Arbete och Hälsa 2002;11:1-38.
The butyl acetates are colourless, flammable liquids with a fruity odour. They are
slightly soluble or insoluble in water, and soluble in ethanol and ether. The butyl
acetates occur in natural and food products, but are also produced chemically. The
main use of butyl acetates is as solvents in paints and lacquers. There are no
quantitative data on the absorption of butyl acetate isomers. Butyl acetates are
quickly metabolised in the body to acetic acid and their respective butanols; tert-
butyl acetate, however, slower than the tree other isomers. Based on human
experimental data the critical effect of occupational exposure to n-butyl acetate is
irritation of eyes, skin and mucous membranes. For isobutyl acetate, irritation is
probably the critical effect, but the data are less convincing. For the other isomers,
there are no data indicating a critical effect.
Keywords: Butyl acetates, Hazard assessment, Irritation, Occupational Exposure
Limit, Toxicity.
11. Summary in Swedish
Stouten H, Bogaerts W. DECOS and SCG Basis for an Occupational Standard.
n-, iso-, sec-, and tert-Butyl acetate. Arbete och Hälsa 2002;11:1-38.
Butylacetater är vid rumstemperatur färglösa lättantändliga vätskor med fruktig
lukt. De är något lösliga eller olösliga i vatten och lösliga i etanol och eter.
Butylacetater förekommer naturligt i livsmedel men produceras också kemiskt.
Huvudanvändningen är som lösningsmedel i målarfärger och lacker. Det saknas
kvantitativa data om absorptionen av butylacetater hos människa. Butylacetater
hydrolyseras snabbt i kroppen till ättiksyra och respektive butanol, tert-butylacetat
emellertid något långsammare än de andra tre isomererna. Baserat på experimen-
tella humandata är den kritiska effekten vid yrkesmässig exponering för n-
butylacetat irritation av ögon, hud och slemhinnor. För iso-butylacetat torde
irritation vara den kritiska effekten men data är osäkrare. För övriga isomerer
saknas det data för att ange någon kritisk effekt.
Nyckelord: Butylacetater, Hygieniskt gränsvärde, Irritation, Riskbedömning,
Toxicitet.
32
12. References
1. American Conference of Governmental Industrial Hygienists (ACGIH). sec-Butyl acetate. In:
Documentation of the Threshold Limit Values and Biological Exposure Indices. 6th ed.
Cincinnati OH, USA: ACGIH, 1991:166.
2. American Conference of Governmental Industrial Hygienists (ACGIH). tert-Butyl acetate. In:
Documentation of the Threshold Limit Values and Biological Exposure Indices. 6th ed.
Cincinnati OH, USA: ACGIH, 1991:167.
3. American Conference of Governmental Industrial Hygienists (ACGIH). Isobutyl acetate. In:
Documentation of the Threshold Limit Values and Biological Exposure Indices. 6th ed.
Cincinnati OH, USA: ACGIH, 1991:814.
4. American Conference of Governmental Industrial Hygienists (ACGIH). In:TLVs_ and other
occupational exposure values -1999. [CD-ROM]. Cincinnati OH, USA; ACGIH, 1999.
5. American Conference of Governmental Industrial Hygienists (ACGIH). Guide to
occupational exposure values -1999. Cincinnati OH, USA: ACGIH, 1999;16:67.
6. American Conference of Governmental Industrial Hygienists (ACGIH). TLVs® and BELs®.
Threshold Limit Values for chemical substances and physical agents and Biological
Exposure Indices. Cincinnati OH, USA; ACGIH, 2000: 21, 43.
7. Alexandersson R, Hedenstierna G. Respiratory hazards associated with exposure to
formaldehyde and solvents in acid-curing paints. Arch Environ Health 1988;43:222-227.
8. Amoore JE, Hautala E. Odor as an aid to chemical safety: odor thresholds compared with
threshold limit values and volatilities for 214 industrial chemicals in air and water dilution. J
Appl Toxicol 1983;3:272-290.
9. Anonymous. Notice of intended changes - n-butyl acetate and formaldehyde. Appl Occup
Environ Hyg 1992;7:846-851.
10. Anonymous. Shell Chemical reports “surprising” results of n-butyl acetate tests. Pestic Toxic
Chem News 1996;24:16.
11. Anonymous. EG-etiket, EU rectificatie 25e aanpassing. [CD-ROM]. The Hague, the
Netherlands: ten Hagen & Stam, 2000.
12. Arbejdstilsynet. Exposure limit value for substances and materials. Copenhagen, Denmark:
Arbejd-stilsynet, 1996:12 (Instruction no. 3.1.0.2).
13. Arbetarskyddsstyrelsen. Hygieniska gränsvärden och åtgärder mot luftföroreningar. Solna,
Sweden: Arbetarskyddsstyrelsen, 2000:64 (Ordinance AFS 2000:3).
14. BASF AG/NOTOX C. V. Acute inhalation toxicity study of n-butyl acetate in the rat. ‘s
Hertogenbosch, the Netherlands: NOTOX C.V., 1988;ref no 0849/153 (cited from Nor97).
15. BASF AG. Study on the acute inhalation toxicity LC50 of n-butyl acetate in rats 4-hour
exposure. Ludwigshafen, FRG: BASF AG, Abteilung Toxikologie, 1988;proj no
1310001/887001 (cited from Nor97).
16. BASF AG. Study on the acute inhalation toxicity LC50 of n-butyl acetate as a liquid aerosol
in rats 4-hour exposure. Ludwigshafen, FRG: BASF AG, Abteilung Toxikologie, 1988;proj
no 1310535/887063 (cited from Nor97).
17. BASF AG. Study on the acute inhalation toxicity LC50 of n-butyl acetate as a vapor in rats 4-
hour exposure. Ludwigshafen, FRG: BASF AG, Abteilung Toxikologie, 1988;proj no
1310535/887044 (cited from Nor97).
18. van der Belt R, Ebens R, Hoogeveen AW. Onderzoek naar de gezondheidsrisico’s van
beroepsmatige blootstelling in de verfindustrie. Delft, The Netherlands: IMG-TNO,
1982;Deelrapport E, Omgevingsmetingen, Bijlage 1.
33
19. Bennick JE. Acute inhalation toxicity study in rats. Sugar land TX, USA: Stillmeadow, Inc,
1997; Stillmeadow, Inc study no: 3639-97 (available from the National Technical
Information Service, Springfield VA, USA; order no: OTSO0573684-1).
20. Berdowski JJM, Jonker WJ. Industriële emissies in Nederland. Bedrijfsgroepen, individuele
stoffen en verdeling over regio’s. Vijfde inventarisatieronde - 1990. The Hague, The
Netherlands: Ministry of Housing, Physical Planning and Environment, 1993:106,118
(Publikatiereeks Emissieregistratie nr 14).
21. Bernard LG, David RM. n-Butyl acetate. An acute inhalation toxicity study in the rat. HAEL
No. 93-0305, KAN 900710 CAS, No 000123-86-4. Final Report. Rochester NY, USA:
Eastman Kodak Company, Corporate Health and Environmental Laboratories, Toxicologal
Sciences Laboratories, 1994 (lab proj id 93-030512) (by courtesy of the Manager of the Oxo
Process Panel of the Chemical Manufacturers Association, Washington DC, USA).
22. Bernard LG, David RM. n-Butyl acetate. A two-week inhalation probe study. HAEL No. 94-
0305, KAN 900710, Cas No. 000123-86-4. Final Report. Rochester NY, USA: Eastman
Kodak Company, Corporate Health and Environmental Laboratories, Toxicologal Sciences
Laboratories, 1995 (lab proj id: 94030513) (available from the National Technical
Information Service, Springfield VA, USA; order no: OTSO0558851).
23. Bernard LG, David RM. n-Butyl acetate. A thirteen-week subchronic inhalation toxicity study
in the rat. HAEL No. 94-0305, KAN 900710, Cas No. 000123-86-4. Final Report. Rochester
NY, USA: Eastman Kodak Company, Corporate Health and Environmental Laboratories,
Toxicologal Sciences Laboratories, 1996 (lab proj id: 94030517) (available from the National
Technical Information Service, Springfield VA, USA; order no: OTS00558876).
24. Bernard LG, David RM, Hosenfeld RS. n-Butyl acetate. A thirteen-week subchronic
inhalation neurotoxicity study in the rat. HAEL No. 93-0305 and 94-0306, KAN 900710,
CAS No 000123-86-4. Final Report. Rochester NY, USA: Eastman Kodak Company,
Corporate Health and Environmental Laboratories, Toxicologal Sciences Laboratories, 1996
(lab proj id 93-030515).
25. Bisesi MS. Esters. In: Clayton GD, Clayton FE, eds. Patty’s industrial hygiene and
toxicology. 4th ed. New York: J. Wiley & Sons, 1994:2967-3118 (Toxicology; Vol IID).
26. Bos PMJ, Zwart A, Reuzel PGJ. Evaluation of the sensory irritation test for the assessment of
occupational health risk. CRC Crit Rev Toxicol 1992;21:423-450.
27. Bushy Run Research Center (BRRC). n-Butyl acetate: acute vapor inhalation toxicity test in
rats. Export PA, USA: BRRC, 1987;proj rep 50-116 (by courtesy of the Manager of the
CMA Oxo Process Panel Washington DC, USA).
28. Bundesministerium für Arbeit und Sozialordnung. Grenzwerte in derluft am Arbeitsplatz;
Technische Regeln für Gefahrstoffe;TRGS900. FRG: Verlag W. Kolharnmer, 2000;
Bundesarbeitsblatt 2/2000.
29. Commissie van de Europese Gemeenschappen (CEG). In: Bijlage bij Richtlijn 93/72/EEG
van de Commissie van 1 september tot negentiende aanpassing aan de vooruitgang van de
techniek van Richtlijn 67/543/EEG van de Raad betreffende de aanpassing van de wettelijke
en bestuursrechtelijke bepalingen inzake de indeling, de verpakking en het kenmerken van
gevaarlijke stoffen (vervolg). Maastricht, The Netherlands: Ellis Publications, 1993:843-844
(Publicatieblad van de Europese Gemeenschappen L258A, deel II).
30. Dahl AR, Miller SC, Petridou-Fischer J. Carboxylesterases in the respiratory tracts of rabbits,
rats and Syrian hamsters. Toxicol Lett 1987;36:129-136.
31. David RM, Tyler TR, Ouellette R, Faber WD, Banton MI, Garman RH, Gill MW,
O'Donoghue JL. Evaluation of subchronic neurotoxicity of n-butyl acetate vapor.
Neurotoxicology 1998;19:809-822.
32. Debets FMH. Evaluation of the acute inhalation toxicity study of T-3916 in the rat. ‘s
Hertogenbosch, The Netherlands: NOTOX C.V., 1986 (by courtesy of REN Bradfield, 3M,
Bracknell (Berkshire) England).
34
33. De Bortoli M, Mølhave L, Ullrich D. European interlaboratory comparison of passive
samplers for organic vapour monitoring in indoor air. In: Commission of the European
Communities, ed. Diffusive sampling: an alternative approach to workplace air monitoring.
Luxemburg: Office for official publications of the European Communities, 1987: 238-241
(pub no EUR 10555).
34. DeGeorge G. Primary dermal irritation in rabbits. Spinnerstown PA, USA; MB Research
Laboratories, Inc, 1997; MB res proj no: MB 97-6119.03 (available from the National
Technical Information Service, Springfield VA, USA; order no; OTSO0573684-1).
35. DeGeorge G. Primary eye irritation/corrosion in rabbits. Spinnerstown PA, USA: MB
Research Laboratories, Inc, 1997; MB res proj no: MB 97-6119.04 (available from the
National Technical Information Service, Springfield VA, USA; order no: OTS00573684-1).
36. DeGeorge G. Acute dermal toxicity in rabbits/LD50 in rabbits. Spinnerstown PA, USA: MB
Research Laboratories, Inc, 1997; MB res proj no: MB 97-6119.02 (available from the
National Technical Information Service, Springfield VA, USA; order no: OTSO0573684-1).
37. DeGeorge G. Single dose oral toxicity in rats/LD50 in rats. Spinnerstown PA, USA: MB
Research Laboratories, Inc, 1997; MB res proj no: MB 97-6119.01 (available from the
National Technical Information Service, Springfield VA, USA; order no: OTSO0573684-1).
38. Deisinger PJ, English JC. The in vivo pharmacokinetics of n-butyl acetate in rats after
intravenous administration. HAEL No 94-0306, CAS No 00123-86-4, KAN 900710. Final
report. Rochester NY, USA: Eastman Kodak Company, Corporate Health and Environmental
Laboratories, Toxicologal Sciences Laboratories, 1997; lab proj id 94-0306BT01 (only
abstract available from Documents Express, Washington DC, USA; see also Pestic Toxic
Chem News 1997;25:6.
39. De Medinilla J, Espigares M. Contamination by organic solvents in auto paint shops. Ann
Occup Hyg 1988;32:509-513.
40. Devos M, Patte F, Rouault J, Laffort P, Van Gemert LJ. Standardized human olfactory
thresholds. Zeist, the Netherlands; TNO Nutrition and Food Research, 1990;TNO rep
no;2639-A.
41. Deutsche Forschungsgemeinschaft (DFG): Senatskommission zur Prüfung gesundheits-
schädlicher Arbeitsstoffe. MAK- und BAT-Werte-Liste 2000. Maximale Arbeitsplatz-
konzentrationen und biologische Arbeitsstofftoleranzwerte. Weinheim, FRG: Wiley-VCH,
2000;33-34 (Mitteilung 36).
42. DiVincenzo GD, Karsavage WJ. Serum ornithine carbamyl transferase as a liver response test
to organic solvents. Am Ind Hyg Ass J 1974;35:21-29.
43. Doorgeest T, Meijer PB, De Mik G. Chronische effecten tengevolge van blootstelling aan
organische oplosmiddelen. Voorburg, The Netherlands: Directorate General of Labour,
Ministery of Social Affairs and Employment, 1986;rep no S 29-1.
44. Düblin T, Thöne HJ. Quantitative analyses of organic multicomponent mixtures of gases and
vapors in industrial air emissions by IR-spectroscopy. Fresenius Z Anal Chem 1989;335:279-
285.
45. European Chemical Industry Ecology & Toxicology Centre (ECETOC). Eye irritation:
reference chemicals databank. Brussels, Belgium: ECETOC, 1992:A9-10 (Technical Report
no 48).
46. Eller PM, ed. NIOSH manual of analytical methods. 3rd ed. Cincinnati OH, USA: DHHS/
NIOSH, 1984;pub no 84-100 (Vol 2).
47. Essig KM, Groth G, Freundt KJ. Different elimination of n-butyl acetate and t-butyl acetate.
Arch Pharmacol 1989;Suppl 340:R33 (abstr no 87).
48. Food and Agriculture Organization/World Health Organization (FAO/WHO): Joint
FAO/WHO Expert Committee on Food Additives (JECFA). Butyl acetate. In: Summary of
evaluations performed by the Joint FAO/WHO Expert Committee on Food Additives
(JECFA). 1956-1993 (first through forty-first meetings). USA: ILSI Press, 1994:B-12.
35
49. Franke JP, Wijsbeek J, De Zeeuw RA, Moller MR, Niermeyer H. Systematic analysis of
solvents and other volatile substances by gas chromatography. J Anal Toxicol 1988;12:20-24.
50. Gad SC, Dunn BJ, Dobbs DW, Reilly C, Walsh RD. Development and validation of an
alternative dermal sensitization test: the mouse ear swelling test (MEST). Toxicol Appl
Pharmacol 1986;84:93-114.
51. Gentry SJ, Walsh PT. Eight-hour TWA personal monitoring using a diffusive sampler and
short-term stain tube. Am Ind Hyg Assoc J 1987;43:287-92.
52. Greim H, ed. 1-Butylacetat. iso-Butylacetat. 2-Butylacetat. tert-Butylacetat. In: Gesund-
heitsschädliche Arbeitsstoffe. Toxikologisch- arbeitsmedizische Begründungen von MAK-
Werten (Maximale Arbeitsplatzkonzentrationen). Ist- 29th ed. Weinhem, FRG: Wiley-VCH,
1999.
53. Groth G, Freundt KJ. Blutalkohol unter Anwesenheit von n-Butylacetat. Blutalkohol
1991;28:166-173.
54. Groth G, Freundt KJ. Inhaled tert-butyl acetate and its metabolite tert-butyl alcohol
accumulate in the blood during exposure. Hum Exp Toxicol 1994;13:478-480.
55. Hackett PL, Brown MG, Buschbom RL, Clark ML, Miller RA, Music RL, Rowe SE,
Schirmer RE, Sikov MR. Teratogenic study of ethylene and propylene oxide and n-butyl
acetate. Springfield VA, USA: National Technical Information Service/US Dept of
Commerce, 1983;rep no PB83-258038.
56. Health Council: Dutch Expert Committee on Occupational Standards (DECOS). 1-, 2- and t-
Butanol. Health-based Recommended Occupational Exposure Limit. The Hague: Health
Council of The Netherlands, 1994; pub no 1994/10.
57. Hiipakka D, Samimi B. Exposure of acrylic fingernail sculptors to organic vapors and
methacrylate dusts. Am Ind Hyg Assoc J 1987;48:230-237.
58. Hoff T. Delayed contact dermal sensitization test -Buehler method. Spinnerstown PA, USA:
MB Research Laboratories, Inc, 1997; MB res proj no: MB 97-6119.06 (available from the
National Technical Information Service, Springfield VA, USA; order no: OTSO0573684-1).
59. Health and Safety Executive (HSE). EH40/2000. Occupational Exposure Limits 2000.
Sudbury (Suffolk), England: HSE Books, 2000;13:20.
60. Hunter WI, Aresini G, Haigh R, Papadopoulos P, Von der Hude W. Occupational exposure
limits for chemicals in the European Union. Occup Environ Med 1997;54:217-222.
61. Iregren A, Loef A, Toomingas A, Wang Z. Irritation effects from experimental exposure to n-
butyl acetate. Am J Ind Med 1993;24:727-742.
62. Ishidate MJ, Sofuni T, Yoshikawa K, Hayashi M, Nohmi T, Sawada M, Matsuoka A. Primary
mutagenicity screening of food additives currently used in Japan. Food Chem Toxicol
1984;22:623-636.
63. Ivanetich KM, Lucas S, Marsh JA, Ziman MR, Katz ID, Bradshaw JJ. Organic compounds.
Their interaction with and degradation of hepatic microsomal drug-metabolizing enzymes in
vitro. Drug Metab Dispos 1978;6:218-225.
64. Kaneko T, Wang PY, Sato A. Partition coefficients of some acetate esters and alcohols in
water, blood, olive oil, and rat tissues. Occup Environ Med 1994;51:68-72.
65. Kay IH. Report to the Texas Company. Toxicity studies on TFA-168. Northbrook IL, USA:
Industrial 810- TEST Laboratories, Inc, 1953 (available from the National Technical
Information Service, Springfield VA, USA; order no: OTS00556824).
66. Kennah HE II, Hignet S, Laux PE, Dorko JD, Barrow CS. An objective procedure for
quantitating eye irritation based upon changes of corneal thickness. Fundam Appl Toxicol
1989;12:258-268.
67. Korsak Z, Rydzynski K. Effects of acute combined inhalation exposure to n-butyl alcohol and
n-butyl acetate in experimental animals. Int J Occup Med Environ Health 1994;7:273-280.
68. Kristensson J, Beving H. A study of painters occupationally exposed to water and solvent
based paints. In: Commission of the European Communities, ed. Diffusive sampling: an
36
alternative approach to workplace air monitoring. Luxembourg: Office for official
publications of the European Communities, 1987:71-4 (pub no EUR 10555).
69. Kronevi T, Wahlberg J, Holmberg B. Histopathology of skin, liver, and kidney after
epicutaneous administration of five industrial solvents to guinea pigs. Environ Res
1979;19:56-69.
70. Kruize I. Bepaling van de geurdrempelwaarde van een zestal oplosmiddelen. Apeldoorn, the
Netherlands: TNO Environment, Energy and Process Innovation, 1988; TNO rep no: MT 88-
339.
71. Kurppa K, Husman K. Car painter’s exposure to a mixture of organic solvents. Serum
activities of liver enzymes. Scand J Work Environ Health 1982;8:137-140.
72. Longland RC, Shilling WH, Gangolli SD. The hydrolysis of flavouring esters by artificial
gastrointestinal juices and rat tissue preparations. Toxicology 1977;8:197-204.
73. Lundberg I, Hakansson M. Normal serum activities of liver enzymes in Swedish paint
industry workers with heavy exposure to organic solvents. Br J Ind Med 1985;42:596-600.
74. Maarse H, Visscher CA, eds. Volatile compounds in food: qualitative and quantitative data.
6th ed. Zeist, The Netherlands: TNO-CIVO Food Analysis Institute, 1989: 1127 (Vol I,
products 1-66).
75. Muller J, Greff G. Recherche de relations entre toxicité de molécules d’interêt industriel et
propiétés physico-chimiques: test d’irritation des voies aériennes supérieures appliqué à
quatre familles chimiques. Food Chem Toxicol 1984;22:661-664.
76. Munch JC. Aliphatic alcohols and alkyl esters: Narcotic and lethal potential to tadpoles and to
rabbits. Int J Med Surg 1972;41:31-33.
77. Myers RC, Tyler TR. Acute toxicologic evaluation of n-butyl acetate. Acute Toxic Data
1992;1:196.
78. Nachreiner DJ, Dodd DE. n-Butyl acetate: acute vapor inhalation toxicity test in rats. Export
PA, USA: Bushy Run Research Center, 1987; proj rep 50-135 (by courtesy of the Manager of
the CMA Oxo Pocess Panel, Washington DC, USA).
79. Nachreiner DJ. n-Butyl acetate (old production process material): acute inhalation toxicity
study. Export PA, USA: Bushy Run Research Center, 1993 (lab proj id 91U0111) (by
courtesy of the Manager of the Oxo Process Panel of the Chemical Manufacturers
Association, Washington DC, USA).
80. Nachreiner DJ. n-Butyl acetate, urethane grade (current production material): acute
inhalation toxicity study. Export PA, USA: Bushy Run Research Center, 1994 (lab proj id
92U1102) (by courtesy of the Manager of the Oxo Process Panel of the Chemical
Manufacturers Association, Washington DC, USA).
81. Nelson KW, Ege JF, Ross M, Woodman LE, Silverman L. Sensory response to certain
industrial solvent vapors. J Ind Hyg Toxicol 1943;25:282-285.
82. US National Institute of Occupational Safety and Health (NIOSH). In: Registry of Toxic
Effects of Chemical Substances (RTECS) [CD-ROM], issue July 2000. SilverPlatter
International, 2000 (last update separate butyl acetate files: July 2000).
83. US National Library of Medicine (NLM). In: Hazardous Substances Data Bank (HSDB)
[CD-ROM], issue August 2000. SilverPlatter International, 2000 (last update separate butyl
acetate files: February 2000).
84. Norbäck D, Wieslander G, Edling C. Occupational exposure to volatile organic compounds
(VOCs), and other air polutants from the indoor application of water-based paints. Ann
Occup Hyg 1995;39:783-794.
85. Norris IC, Nachreiner DI, Tyler TR, Klimisch HJ, Zimmerman DD. Acute inhalation toxicity
studies of n-butyl acetate. Inhal Toxicol 1997;7:623-646.
86. Opdyke DLJ. Monographs on fragrance raw materials. Isobutyl acetate. Food Cosmet Toxicol
1978;16:795-796.
37
87. Opdyke DLJ. Monographs on fragrance raw materials. Butyl acetate. Food Cosmet Toxicol
1979;17:515-519.
88. Ørbræk P, Österberg K, Åkesson B, Bergendorf U, Karlson B, Seger L. Suprathreshold
intensity and annoyance reactions in experimental challenge to toluene and n-butyl acetate
among subjects with long-term solvent exposure. Scand I Work Environ Health 1998;24:432-
438.
89. Österberg K, Ørbræk P, Karlson B, Seger L, Åkesson B, Bergendorf U. Psychological test
performance during experimental challenge to toluene and n-butyl acetate in cases of solvent-
induced toxic encephalopathy. Scand I Work Environ Health 2000;26:219-226.
90. Pellizzari ED. Analysis for organic vapor emissions near industrial and chemical waste
disposal sites. Environ Sci Technol 1982;16:781-785.
91. Peng HM, Raner GM, Vaz ADN, Coon MJ. Oxidative cleavage of esters and amides to
carbonyl products by cytochrome P450. Arch Biochem Biophys 1995;318:333-339.
92. Petren S, Vesterberg O. Studies of transferrin in serum of workers exposed to organic
solvents. Br J Ind Med 1987;44:566-568.
93. Roed-Petersen J. Allergic contact dermatitis from butyl acetate. Contact Dermatitis
1980;6:55.
94. Rothweiler H, Waeger PA, Schlatter C. Volatile organic compounds and some very volatile
organic compounds in new and recently renovated buildings in Switzerland. Atmos Environ
(Part A) 1992;26A:2219-2225.
95. Roudabush RL. Toxicity and health hazard summary of sec-butyl acetate. Rochester NY,
USA: Eastman Kodak Company, Laboratory of Industrial Medicine, 1970 (available from the
National Technical Information Service, Springfield VA, USA; order no: OTS00556683).
96. Sala C. Passive sampling with liquid or solid substrate. In: Commission of the European
Communities, ed. Luxembourg: Office for official publications of the European
Communities, 1987: 262-5 (pub no EUR 10555).
97. Samimi B. Exposure to isophorone and other organic solvents in a screen printing plant. Am
Ind Hyg Assoc J 1982;43:43-48.
98. Sayers RR, Schrenk HH, Patty FA. Acute response of guinea pigs to vapors of some new
commercial organic solvents. n-Butyl acetate. Pub Health Rep 1936;51:1229-1239.
99. Scheffers TML, Jongeneelen FJ, Bragt PC. Development of effect-specific limit values
(ESLVs) for solvent mixtures in painting. Ann Occup Hyg 1985;29:191-199.
100. Seifert B, Mailahn W, Schulz C, Ullrich D. Seasonal variation of concentrations of volatile
organic compounds in selected German homes. Environ Int 1989;15:397-408.
101. Shimizu H, Suzuki Y, Takemura N, Goto S, Matsushita H. The results of microbial mutation
test for forty-three industrial chemical. Jpn J Ind Health 1985;27:400-419.
102. Shulman RN. Letter and attachment (dd March 13) to the Document Processing Center of the
Office of Toxic Substances of USEPA. Washington DC, USA. Houston TX, USA: Shell
Chemical Company, Health, Safety and Environment, 1996 (available from Documents
Express, Washington DC, USA; see also Ano96).
103. Smyth HF, Carpenter CP, Weil CS, Pozzani UC. Range finding toxicity tests. List V. Arch
Ind Hyg Occup Med 1954;10:61-68.
104. Smyth HF, Carpenter CP, Weil CS, Pozzani UC, Striegel JA. Range-finding toxicity data.
List VI. Arch Ind Hyg Occup Med 1962;23:95-107.
105. Spingarn NE, Northington DJ, Pressely T. Analysis of volatile hazardous substances by
GC/MS. J Chromatogr Sci 1982;20:286-288.
106. Studiegroep Chemiekaarten, eds. In: Chemiekaarten: gegevens voor het veilig werken met
chemicaliën. 11 th ed. Alphen a/d Rijn, the Netherlands: Samson HD Tjeenk Willink bv,
1997:176,177,607.
38
107. Streete PJ, Ruprah M, Ramsey JD, Flanagan RJ. Detection and identification of volatile
substances by headspace capillary gas chromatography to aid the diagnosis of acute
poisoning. Analyst (London) 1992;117:1111-1127.
108. Syracuse Research Corp: Center for Chemical Hazard Assessment. Information profiles on
potential occupational hazards. Volume 1. Single chemicals. n-Butyl acetate. Springfield
VA, USA: National Technical Information Service/US Dept of Commerce, 1979; rep no
PB81-147993.
109. Ministerie van Sociale Zaken en Werkgelegenheid (SZW). De nationale MAC-Iijst 1999. The
Hague, The Netherlands: Servicecentrum Sdu Uitgevers, 1999:19,30.
110. Toy NJ. Final report on the safety assessment of ethyl acetate and butyl acetate. J Am Coll
Toxicol 1989;8:681-705.
111. Triebig G, Schaller KH. Arbeitsmedizinische Untersuchungen zur Gefahrstoffbelastung von
Malern und Lackierern. Staub - Reinhalt Luft 1991;51:1-4.
112. Uehori R, Nagata T, Kimura K, Kudo K, Noda M. Screening of volatile compounds present
in human blood using retention indexes in gas-chromatography. J Chromatogr 1987;411:251-
257.
113. van der Wal JF, van de Belt R. Expositie van werknemers in een lijmfabriek aan lucht-
verontreininging. Delft, the Netherlands: IMG-TNO, 1984; rep no F2171.
114. Wang JD, Chen JD. Acute and chronic neurological symptoms among paint workers exposed
to mixtures of organic solvents. Environ Res 1993;61:107-116.
115. Weller JP, Wolf M. Mass spectroscopy and headspace-GC. Beitr Gerichtl Med 1989;47:525-
532.
116. World Health Organization (WHO): International Programme on Chemical Safety (IPCS).
Environmental Health Criteria 65. Butanols - four isomers: 1-butanol, 2-butanol, tert-
butanol, isobutanol. Geneva, Switzerland: WHO, 1987.
117. Williams CH. Exposure assessment study for n-butyl acetate in paint spray aerosols. Volume
1, Report. Austin TX, USA: Radian Corporation, 1995 (by courtesy of the Manager of the
Oxo Process Panel of the Chemical Manufacturers Association, Washington DC, USA).
118. Winder C, Turner PJ. Solvent exposure and related work practices amongst apprentice spray
painters in automotive body repair workshops. Ann Occup Hyg 1992;36:385-394.
119. Zaleski J. Butyl acetates. In: Thurman RG, Kaufman FC, eds. Ethel Browning’s toxicity and
metabolism of industrial solvents. 2nd ed. Amsterdam, The Netherlands: Elsevier Science
Publishers BV, 1992: 247-55 (Alcohols and ethers; Vol 3).
120. Zeiger E, Anderson B, Haworth S, Lawlor T, Mortelmans K. Salmonella Mutagenicity tests:
V. Results form the testing of 311 chemicals. Environ Mol Mutagen 1992;19 Suppl 21:2-141.
121. Zimmerman FK, Mayer VW, Scheel I, Resnick MA. Acetone, methyl ethyl ketone, ethyl
acetate, acetonitrile and other polar aprotic solvents are strong inducers of aneuploidy in
Saccharomyces cerevisiae. Mutat Res 1985;149:339-351.
Submitted for publication July 8, 2002.
2001
7 K Isaksson, G Aronsson, K Bellaagh
and S Göransson. Att ofta byta arbets-
plats. En jämförelse mellan uthyrda och
korttidsanställda.
8 B-M Larsson. Induction of a non-allergic
inflammation in the human respiratory tract
by organic dust.
9 G M Hägg. Arbetslivsinstitutets expert-
grupp för ergonomisk dokumentation –
dokument 3. Handintensivt arbete. En
belastningsergonomisk kunskapsöversikt
gällande människans kapacitet och inter-
aktion med verktyg och arbetsuppgifter.
10 M Hagberg, B Knave, L Lillienberg and
H Westberg (Eds). X2001 – Exposure
Assessment in Epidemiology and Practice.
11 J Höög and M Stattin. Förtidspensionärer
i ett tioårsperspektiv. En jämförelse av de
nya förtidspensionärerna 1988, 1993 och
1998.
12 T Hansson and P Westerholm (ed).
Arbete och besvär i rörelseorganen. En
vetenskaplig värdering av frågor om sam-
band.
13 J Wahlström. Physical load in computer
mouse work. Working technique, sex and
stress aspects.
14 K Svendsen. The Nordic Expert Group for
Criteria Documentation of Health Risks
from Chemicals and The Dutch Expert
Committee on Occupational Standards.
127. Hydrogen sulphide.
15 M Mortimer. Low back pain in a general
population. Care seeking behaviour,
lifestyle factors and methods of exposure
assessment.
16 W Astvik, E Bejerot and I-L Petterson.
Gränser i omsorgsarbete. En studie om
arbetets innehåll, villkor och kvalitet,
17 C Bildt and L Karlqvist (eds). Women’s
conditions in working life.
18 B Lindell and J Montelius. The Nordic
Expert Group for Criteria Documentation
of Health Risks from Chemicals.
128. Triglycidyl isocyanurate.
19 Kriteriegruppen för hygieniska gräns-
värden. Ed. J Montelius. Vetenskapligt
Underlag för Hygieniska Gränsvärden 22.
20 Criteria Group for Occupational Stan-
dards. Ed. J Montelius. Scientific Basis
for Swedish Occupational Standards XXII.
2002
1 A-B Antonsson, L Birgersdotter and
S Bornberger-Dankvardt. Small enterpri-
ses in Sweden. Health and safety and the
significance of intermediaries in preventive
health and safety.
2 H Stouten, F Rutten, I van de Gevel and
F de Vrijer. The Nordic Expert Group for
Criteria Documentation of Health Risks
from Chemicals and The Dutch Expert
Committee on Occupational Standards.
129. Chlorotrimethylsilane.
3 C Müller-Suur. Organic dust from pig
environment induces activation of human
T cells.
4 M Sandström, U Bergqvist, R Küller,
T Laike, A Ottosson and R Wibom.
Belysning och hälsa – en kunskapsöversikt
med fokus på ljusets modulation, spek-
tralfördelning och dess kronobiologiska
betydelse.
5 P Nylén, U Bergqvist, T Fischer,
A Glansholm, J Hansson, J Surakka,
P Söderberg and U Wester. Ultraviolett
strålning och hälsa – ett kunskapsunderlag.
6 L Hallsten, K Bellaagh and K Gustafsson.
Utbränning i Sverige – en populationsstudie.
7 P Westerholm (ed). Psykosocial belast-
ning och riskfaktorer för hjärt-kärlsjukdom.
Minisymposium i WOLF-projektet 8
februari 2001.
8 G Aronsson and K Gustafsson. Sjuk-
närvaro – förekomst och utvecklings-
tendenser.
9 S-G Servais, S Häggqvist, E Söderman,
L Backman, K Grundberg, A Lundin, I-
L Petterson and M Åhman. Arbetsmiljö-
kvalitet i skolan. Utvärdering av en arbets-
miljöintervention baserad på samverkan.
10 B Westrum and Y Thomassen. The
Nordic Expert Group for Criteria Docu-
mentation of Health Risks from Chemicals
and  and The Dutch Expert Committee on
Occupational Standards. 130. Tin and
inorganic tin compounds.
11 Hans Stouten and Wim Bogaerts.
DECOS and SCG Basis for an Occupa-
tional Standard. n-, iso-, tert-Butyl acetat.
Latest issues in NIWL’s scientific serial
arbete och hälsa
2000
1 Ylva Waldemarson: Kvinnor och klass –
en paradoxal skapelseberättelse. LOs
Kvinnoråd och makten att benämna
1898–1967.
2 Jonas Malmberg (ed): Låglönekonkurrens
och arbetstagares integritet. Rapporter till
Nordiskt arbetsrättsligt möte 2000.
3 Cajsa Lagerkvist: Världar emellan?
Frågan om etnisk mångfald i kulturlivet.
Förstudie om invandrade kultur- och
mediearbetares situation på arbetsmark-
naden, med diskussion om vidare forsk-
ning.
2001
1 Birgitta Edelman: Arbetslivsforskningen
– quo vadis? Antropologisk forskning och
arbetets kulturer.
2 Johan M Sanne: Arbete, arbetsorganisa-
tion och arbetsmarknad för kultur- och
medieverksamma. Översikt över forskning
och utredning.
3 Amanda Lagerkvist: Från kulturimperia-
lism till hybriditet. En översikt över teorier
och litteratur om kulturspridning.
4 Eskil Ekstedt (ed): Kunskap och handling
för företagande och regional utveckling.
5 Kurt Lundgren and Lars-Martin Liljen-
vall: Distansundervisning som stöd
för livslångt lärande i arbetslivet.
6 Arja Tyrkkö and Hanna Westberg:
Förskjutning i segregeringsmönster på
yrkesnivå. Bearbetning av folk- och
bostadsräkningarna 1970–1990 och
arbetsmiljöundersökningarna 1989–1995
7 Sophia Ivarsson: Kvinnors karriärväg mot
chefskap – om könsrelaterade mönster i
karriärutvecklingsprocessen.
8 Anders Wikman: Internationalisering,
flexibilitet och förändrade företagsformer.
En statistisk analys av arbetsställenas
utveckling under 90-talet.
9 Annette Thörnquist (ed): Work Life,
Work Environment and Work Safety in
Transition. Historical and Sociological
Perspectives on the Development in
Sweden during the 20th Century.
10 Michael Allvin: Distansarbete. Ett instru-
ment för frihet eller kontroll?
11 Inga-Britt Drejhammar and Birgit
Pingel: Kvinnor är lika bra arbetskraft
som män, men olika. Jämställdhetsarbete i
östgötska organisationer.
2002
1 Lotte Alsterdal: Hertig av ovisshet
– aspekter på yrkeskunnande. Andra,
reviderade upplagan.
2 Åke Sandberg and Fredrik Augustsson:
Interactive Media in Sweden 2001. The
Second Interactive Media, Internet and
Multimedia Industry Survey.
3 Nils Elvander: Industrial Relations: A
Short History of Ideas and Learning.
4 Anders Wikman: Temporära kontrakt och
inlåsningseffekter.
5 Kerstin Sörensen and Christina Berg-
qvist: Gender and the Social Democratic
Welfare Regime. A comparison of gender-
equality friendly policies in Sweden and
Norway.
6 Lena Wilhelmson and Marianne Döös:
Sustainability and innovative organisational
change. Identifying and dealing with non-
synchronised processes in a rapidly
changing environment.
7 Lennart Svensson, Göran Brulin, Per-
Erik Ellström and Örjan Widegren (red):
Interaktiv forskning – för utveckling av teori
och praktik.
8 Anette Forsberg, Chatrine Höckertin
and Hans Westlund: Socialt kapital i
lokalt utvecklingsarbete.
Latest issues in NIWL’s scientific serial
work life in transition


